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ABSTRACT
Equine infectious anemia virus (EIAV) is the causative agent of a 
persistent disease in horses. The long terminal repeat (LTR) region of EIAV 
contains the enhancer and promoter elements necessary for transcription of the 
proviral genome. The LTR is also prone to a high degree of sequence variability 
between different virus isolates. Sequence alignments of LTR variants from both 
tissue culture-adapted strains of the virus as well as sequential horse isolates 
showed a high degree of sequence variability between variants. Sequence 
variability was further localized to a hypervariable region approximately 60 bp 
upstream of the TATA box. This region contained insertions resulting in the 
duplication of flanking sequences and the putative m-elements they contain. 
Transient gene expression analysis of the LTR variants in three different cell lines 
showed that the promoter activities of the LTR variants were different and that 
these differences were cell line dependent. Further analysis using deletion 
mutants indicated that the hypervariable and flanking regions contained several 
cw-elements important for promoter activity and that duplication of these elements 
increased activity under basal conditions. Analysis of infected horse tissue DNA 
using competitive PCR analysis did not indicate a high degree of sequence 
divergence localized to the LTR. Therefore, LTR heterogeneity may not be 
required for the onset of acute disease. To assess the impact of LTR variability 
on viral replication kinetics and cytopathogenicity, an infectious EIAV molecular 
clone was created in which the cognate LTR region was replaced with the 
corresponding region of a virus stock which demonstrates accelerated 
cytopathogenic effects. The study showed that the LTR increased replication 
capacity but did not influence cytopathogenicity.
vi
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CHAPTER 1 
LITERATURE REVIEW
Retroviruses
The retrovirus family of viruses is arguably the most studied group of 
pathogens in human history. Initially identified in the early 1900s as filterable 
agents associated with diseases in animals, retroviruses were not linked to any 
human diseases until almost eighty years later with the discovery of the Human T- 
cell leukemia virus (HTLV), and Human immunodeficiency virus (HIV) (Wong- 
Staal, 1991).
Structure
Retroviruses are enveloped RNA viruses with a virion size of approximately 
100 nm and a conical nucleocapsid (Fig. 1 A). The envelope is derived from the 
plasma membrane of the host. Imbedded within it are viral glycoproteins, the 
products of the env gene, that form knob-like structures on the exterior of the virion 
and are essential for the recognition, attachment, and penetration of the virus into 
the host cell. The interior of the virion is dominated by the viral capsid. This 
structure is formed from the multiple protein products of the gag gene. In addition 
to the capsid, the interior of the virion contains several enzymatic activities required 
for retrovirus replication. Such as the reverse transcriptase, ribonuclease H (RNase 
H), and integrase enzymes encoded by the pol gene. Virion cores also contain host 
tRNA which functions as a primer during the reverse transcription of the viral 
genomic RNA and, in some cases, auxiliary proteins such as the viral infectivity 
factor (Vif) of HIV. Associated with the nucleocapsid is the positive strand, diploid 
RNA genome. These identical strands of RNA, from 7 to 10 kb in length, possess a 
7mG cap at their 5' ends and are poly-adenylated like host mRNA.
1
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Figure 1. Retrovirus virion and genomic structure. (Panel A). Structure of a 
general retrovirus virion. (Panel B) Sequence features of a retroviral genomic 
RNA (adapted from Coffin, 1991).
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3The retroviral genome contains three main open reading frames which form 
the gag,pol, and env genes (Fig. IB). These genes produce the structural proteins 
and enzymes necessary for viral replication. Smaller open reading frames may also 
be present which can produce auxiliary gene products such as the transactivation 
protein (Tat) of HIV. The ends of retroviral genomic RNA are terminally 
redundant. A non-coding region, R, at the capped 5' end is repeated again at the 3' 
end of the genome just prior to the poly-adenine tail. R is followed at the 5' end by 
U5 and non-coding leader regions, while it is preceded at the 3’ end by the U3 
region. U5 contains the poly-adenylation signal sequence while U3 contains the 
viral promoter and enhancer elements necessary for transcription of the viral 
genome after infection (Coffin, 1991).
Reverse Transcription and Integration
The unique mechanism by which retroviruses replicate is one of the most 
defining characteristics of this viral family. Upon penetration of the host cell, the 
viral genomic RNA undergoes reverse transcription to form a double-stranded 
DNA copy or provirus. This process originates at a host derived tRNA molecule 
bound to a complementary primer binding site (PBS) which lies adjacent to the 5' 
U5 region. This bound tRNA serves as the primer for the viral reverse transcriptase 
enzyme which begins to create a DNA strand complementary (negative-sense) to 
the viral RNA. As the U5 and R regions are copied, they are degraded by the viral 
RNase H activity. Because the template is degraded as it is copied, the nascent 
DNA strand dissociates from the template when the 5' end is reached. The nascent 
DNA strand is then free to re-associate with the complementary R region at the 3' 
end of the template and reverse transcriptase continues to elongate the 
complementary DNA strand. This is referred to as strand jumping. During the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4synthesis of negative-strand DNA, a positive-strand is being produced as well. The 
RNase H activity cleaves the template RNA at a precise point adjacent to the U3 
region. This recognition sequence is referred to as the poly-purine tract due to its 
tendency to contain strings of adenine and guanine residues. The cut template 
RNA and negative-stranded DNA form the primer complex for reverse 
transcriptase. After the U3, R, U5, and PBS regions have been successfully copied, 
the positive-strand DNA jumps to complementary sequences at the opposite end of 
the negative-strand DNA. Both positive and negative DNA strands are then 
completed by reverse transcriptase to form the provirus. Not only is this 
mechanism unique due to its reversal of the conventional flow of genomic 
information, but it also results in a rearrangement of the viral genome at the same 
time. Unlike the RNA genome, the U3, R and U5 regions are clustered together 
and repeated at both ends of the pro virus. Collectively, these three regions make up 
the long terminal repeat or LTR.
After being copied into a proviral form, the retrovirus integrates itself into 
the genome of the host. The exact mechanism by which this occurs is not 
completely understood but it is known that the reaction requires both the viral 
capsid as well as the integrase enzyme. Staggered cuts are made at both ends of the 
provirus resulting in 5' overhangs. In a linked reaction, staggered cuts are made 
within the host genomic DNA and these are linked to the cut provirus.
Subsequently, any gaps or nicks in the DNA are repaired by a host repair enzyme. 
This results in an intact provirus, minus one to two base pairs from each end, being 
inserted into the host’s genome. During this reaction, linear pro virus can become 
linked to itself forming a closed, circular piece of extra-chromosomal DNA.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5Within an infected cell, both these forms of provirus are readily detectable (Coffin, 
1991).
Gene Expression
Once integrated into the host genome, the pro virus uses the host’s own 
transcriptional and translational machinery to create progeny virions. The U3 
region of the LTR contains the single promoter for the entire retroviral genome. It 
contains the TATA box as well as most, if not all, enhancer elements. As these 
elements bind cellular transcription factors, they influence both the type and state of 
the host cell in which the virus may be transcribed as well as the rate at which 
transcription occurs. The actual transcription start site lies downstream of the 
TATA box and forms the demarcation between the U3 and R regions.
Transcription then proceeds through the proviral genome to the U5 region of the 3' 
LTR which contains the poly-adenylation signal sequence. The point on the viral 
mRNA where poly-adenylation begins forms the boundary between the R and U5 
regions. This full-length transcript may be transported to the cytoplasm where it 
forms the genomic RNA in progeny virions or be translated to produce the gag and 
gag-pol polyproteins. In a minority of cases, a translational error may occur 
resulting in the production of the pol gene products. Alternatively, the full-length 
transcript may stay within the nucleus and be spliced to form a variety of smaller 
viral mRNA species. These singly or multiply-spliced mRNAs are responsible for 
the production of the env polyprotein as well as auxiliary proteins. Virion assembly 
and subsequent budding occurs at the plasma membrane. Although the 
polyproteins produced by gag, pol, and env undergo some proteolytic cleavage 
prior to virion assembly and release, complete cleavage of the polyproteins and 
maturation of the virion occurs after budding (Coffin, 1991).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6Taxonomy
The family Retroviridae is subdivided into three subfamilies; the 
Oncovirinae, Lentivirinae, and Spumavirinae based on a variety of factors 
including genomic complexity and pathology (Table 1).
Table 1. Retrovirus subfamilies 
Subfamily Isolates
Oncovirinae
Lentivirinae
Spumavirinae
Rous sarcoma virus 
Rous-associated virus 1-50 
Feline leukemia virus 
Mouse Mammary tumor virus 
Bovine leukemia virus 
Human T-cell leukemia virus 
Rous-associated virus type 0 
Human immunodeficiency virus 
Simian Immunodeficiency virus 
Feline immunodeficiency virus 
Visna/maedi virus 
Equine infectious anemia virus 
Human foamy virus 
Simian foamy virus
Pathology 
acute, exogenous 
non-acute, exogenous 
non-acute, exogenous 
non-acute, exogenous 
non-acute, exogenous 
non-acute, exogenous 
benign, endogenous
Oncoviruses have been identified in a variety of animal species including 
humans and although usually exogenous, certain strains such as Rous-associated 
virus type 0 are endogenous. Many oncoviruses, but not all, cause transformation
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7of in vitro cell cultures and induce tumors within their natural hosts. While some 
oncoviruses actually contain oncogenes and rapidly cause disease, there are many 
members that do not encode oncogenes but are still involved in tumorigenesis and 
still others that cause no disease at all. Therefore they are classified as acute, non­
acute, and benign. Most oncoviruses are genetically quite simple. Few produce 
any auxiliary proteins other than an oncogene. HTL V, the causative agent of adult 
T-cell lymphoma, is one of the most complex oncoviruses in that it produces two 
auxiliary proteins Tax and Rex. Both of these proteins perform regulatory 
functions. Tax interacts with cellular transcription factors, bound to specific cis- 
elements within the U3 region, and stimulates transcription. The presence of Rex 
results in the production of more full-length or singly-spliced viral mRNA 
transcripts relative to the multiply-spliced transcripts that produce itself and Tax. 
These proteins are similar to those produced by lentiviruses (Coffin, 1991).
Lentiviruses are probably the most significant subfamily of retroviruses 
from a pathology standpoint as this group includes the HTV virus, the causative 
agent of the acquired immunodeficiency syndrome (AIDS). Since its discovery in 
the early 1980s, HIV is believed to have infected more than 13 million people 
world-wide. By the year 2000, that number may reach 40 million. Despite intense 
research efforts this virus continues to exhibit a fatality rate of nearly 100% 
(Cowley et al., 1995). Lentiviruses differ significantly from the oncoviruses in 
pathology and genomic complexity. These viruses usually cause slow, progressive 
infections that can lead to auto-immune or immunodeficiency diseases within the 
host. They are also more genetically complex than the oncoviruses because they 
produce a number of auxiliary proteins. The most universal of these proteins are 
Tat and Rev. The HTV Tat protein, in conjunction with cellular proteins, interacts
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8with a stem-loop structure, the transactivation response element (TAR), contained 
in nascent viral mRNA transcripts and may either stimulate initiation of 
transcription or may prevent premature termination by the RNA polymerase II 
complex (Laspia et al., 1989; Selby et al., 1989). This mechanism is not universal 
among lentiviruses. In the case of Visna/Maedi virus for example, there is no TAR 
element present and the analogous Tat protein acts indirectly at the viral LTR in a 
mechanism similar to that of HTLV Tax. Despite these differences, the lentivirus 
Tat protein dramatically increases viral mRNA production. Rev also acts upon 
viral mRNA at a region of extensive secondary structure, the rev-responsive 
element (RRE), and facilitates the transport of viral mRNA into the cytoplasm and 
the subsequent loading of polysomes (Tiley et al., 1992). This results in an 
increase in the ratio of full-length or singly-spliced viral mRNA to multiply-spliced 
viral mRNA thereby increasing production of the structural proteins while 
decreasing the production of auxiliary proteins such as Tat and Rev (Perkine et al.,
1989). Most lentiviruses are also believed to produce a viral infectivity factor, Vif. 
This small protein is packaged within the virion and appears essential for viral 
infectivity in vivo as mutations in Vif can prevent spread of the virus (Von 
Schwedler et al., 1993). In addition to Tat, Rev, and Vif, the primate lentiviruses 
SIV (Simian immunodeficiency virus) and HTV produce the auxiliary proteins Nef, 
Vpu, and Vpr/Vpx. The genes which produce these proteins are often dispensable 
in vitro thus they have not been as extensively studied as Tat and Rev but they 
appear to dramatically affect virulence in vivo. Nef was originally identified as a 
negative regulatory protein that acted upon the LTR to decrease transcription 
initiation. A theory that remains somewhat controversial. Nef is also believed to 
play a role in the endocytosis and lysosomal degradation of CD4, the primary
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9cellular receptor for HIV and SIV (Nebreda et al., 1991). Vpu is a protein unique 
to HIV-1 and appears to perform two different functions. It is involved in both 
virion egress as well as degradation of intra-cellular CD4 (Vincent et al., 1993). 
Virtually nothing is known about the in vivo function of Vpr (HIV-1 and HTV-2) 
and Vpx (HIV-2 and SIV), although some studies have shown that Vpr may act 
upon the HIV LTR to enhance transcription (Clements and Payne, 1994).
The least information is known about the subfamily Spumavirinae, or 
foamy viruses. Viral isolates belonging to this family have been isolated from a 
wide variety of species including humans. Although they have not been shown to 
cause disease, although a study of patients suffering from nasopharyngeal 
carcinoma indicated a high prevalence Human foamy virus (HFV) positive 
individuals. This may indicate an involvement in tumorigenesis. They are dubbed 
foamy viruses due to their cytopathogenic effects when propagated in tissue culture. 
Similar to lentiviruses on a genomic level, the foamy viruses are believed to 
produce at least three auxiliary proteins including one that functions as a 
transactivator similar to Tat (Aquzzi, 1993).
Equine Infectious Anemia Virus
Equine infectious anemia, first described in 1843, is a persistent disease 
affecting members of the genus Equus. In 1904, the disease was linked to a 
filterable agent, the Equine infectious anemia virus. The virus is transmitted to 
susceptible hosts by contaminated blood, the main vector being hematophagous 
insects, where it infects cells of the monocyte/macrophage lineage (Sellon et al., 
1994). Diagnostic tests, the agar gel immunodiffusion and competitive ELISA 
tests, are required by federal quarantine laws governing the interstate transport of 
animals. Estimates place the percentage of infected horses, within the United
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
10
States, at between 0 and 2% depending upon geographic location (Loftine et al.,
1990).
Horses with EIA may undergo three different phases of the disease. Within 
30 days of the initial infection, the horse may develop high titer viremia resulting in 
fever, weight loss, thrombocytopenia, and severe anemia. This is the acute phase of 
the disease and in severe cases may be fatal. EIA is unique among lentiviral 
syndromes due to this rapid emergence of clinical disease. Horses that recover 
from the initial febrile episode may experience additional disease episodes at 
irregular intervals during the first year of infection. Horses that experience multiple 
and severe febrile episodes are described clinically as being in the chronic stage of 
EIA. Both the number of episodes experienced during this phase and the time 
interval between them varies. During the 1980s, researchers discovered that 
emergence of antigenic variants of the virus corresponds to sequential disease 
episodes (Montelaro et al., 1984). Thus EIA became the first disease of lentiviral 
etiology whose persistence was linked to the antigenic variation of the virus.
Horses which harbor the virus yet show no visible signs of disease are described as 
being asymptomatic. Asymptomatic horses can have a recurrence of clinical 
symptoms should they become immuno-compromised at some point in their 
lifetime. In addition, asymptomatic horses are capable of transmitting the disease 
and therefore serve as a reservoir for the virus.
The clinical symptoms of EIA are believed to result from widespread 
immune system activation within the host in response to viremia. Complement 
coated erythrocytes are present in horses during the acute and chronic phases of the 
disease. It is believed that viral glycoproteins or viral glycoprotein/antibody 
complexes associate with the surface of erythrocytes eventually resulting in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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complement mediated lysis or phagocytosis of the affected erythrocytes (Sentsui 
and Kono, 1987). In addition to hemolysis, anemia in horses with EIA is 
exacerbated by a decrease in erythrocyte precursors. As viral proteins do not 
appear to be associated with immature erythrocytes, the reason for their depletion is 
unknown but may be due to an activation of macrophages and subsequent release of 
factors, interleukin 1 and lactoferrin, that affect iron metabolism (McGuire et al., 
1969). A decrease in platelet count, thrombocytopenia, is caused by a similar 
immune-mediated mechanism. During disease episodes, host platelets are bound to 
excessive amounts of IgG and IgM which may cause their subsequent removal by 
phagocytosis (Clabough etal., 1991; Sellon etal., 1994).
Structure
EIAV is classified as a Ientivirus based on pathology, morphology, 
serology, genetic organization, and enzymatic activities. It is an enveloped RNA 
virus, approximate diameter 140 nm, with a conical core. The exterior envelope is 
derived from the plasma membrane of the host cell and is studded with 
glycoprotein spikes. The viral glycoprotein gp90 forms the exterior domain of the 
surface spike while the transmembrane segment is formed by gp45. Both are 
cleaved from a precursor poly-protein encoded by the env gene. The conical core 
of EIAV is formed from four non-glycosylated proteins, p26, pi 5, pi 1, and p9, 
which are products of the gag gene. In addition, the core contains the pol gene 
products which include the reverse transcriptase, protease, deoxyuracil 
triphosphotase (dUTPase), RNase H, and integrase enzymes. EIAV also produces 
two regulatory proteins whose functions are analogous to HIV Tat and Rev, as well 
as possibly two auxiliary proteins of unknown function (Ttm and the ORF S2 
product). The diploid RNA genome consists of capped and poly-adenylated RNA
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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8.2 kb in length. The exact processes of reverse transcription and integration have 
not been elucidated for EIAV but it is believed to behave similarly to that of other 
lentiviruses (Sellon et al., 1994).
Genomic Organization and Expression
The EIAV proviral genome (Fig. 2), like all lentiviruses, is subject to a high 
degree of sequence variability both within a single host and throughout a host 
population. Therefore the nucleotide lengths discussed hereafter must be 
considered approximations. The genome begins with a 5' LTR region which varies 
in length, approximately 300-330 bp, between different virus isolates. This is 
followed by a leader sequence, 143 bp long, which contains a splice donor site used 
in subsequent viral mRNA splicing reactions and the first exon of the EIAV tat 
gene. The leader region ends at the ATG initiation codon for the gag gene. This 
gene, approximately 1500 bp in length, encodes a precursor polyprotein which 
yields the four core proteins upon proteolysis. Overlapping the gag gene by 251 bp 
is the pol gene. Approximately 3400 bp in length, this gene produces the protease, 
reverse transcriptase, RNase H, dUTPase, and integrase enzymatic activities. The 
dUTPase enzyme is only present in a sub-set of the lentivirus group of viruses. 
Those viruses that infect macrophages such as EIAV and Feline immunodeficiency 
virus (FIV) may require this enzyme in order to replicate in this terminally 
differentiated and non-replicating cell type. Immediately following the pol gene is 
a small open reading frame designated as ORF SI which is only about 150 bp long 
and lacks its own initiation codon. This region forms the second exon of the EIAV 
tat gene. Following the stop codon of ORF SI by about 7 bp is another short open 
reading frame ORF S2. This 200 bp region could potentially produce a 66 amino 
acid protein which bears no sequence homology to other known lentiviral proteins
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2. Schematic diagram of the EIAV pro virus and transcripts. Open reading 
frames and their products are illustrated for the proviral genome followed by 
diagrams of possible transcripts produced as well as their respective protein 
products.
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and has no known function although it has been hypothesized to be the EIAV 
equivalent of Vif. ORF S2 almost completely overlaps the env gene. The env gene 
of EIAV is approximately 2600 bp long and produces the polyprotein gpl35 which 
is subsequently cleaved to form the surface protein gp90 and the transmembrane 
protein gp45. Within the env gene region lies another overlapping open reading 
frame, ORF S3, approximately 400 bp long. This region, like ORF SI, contains no 
initiation codon but with subsequent splicing of the mRNA forms a large portion of 
the putative EIAV rev gene. After the stop codon of env lies a short region 17 bp 
long, containing the poly-purine tract, which is followed in turn by the 3' LTR 
(Sellon et al., 1994).
In addition to the main structural and enzymatic proteins, the genome 
encodes a number of auxiliary proteins similar to other lentiviruses. In order to 
accomplish this, EIAV utilizes several splice donor and acceptor sites to create 
singly and multiply-spliced mRNAs (Fig. 2). To produce a functional tat gene, the 
splice donor site within the leader sequence is linked to a splice acceptor site at the 
end ofpol. This creates a singly-spliced mRNA 3.2 kb in length that produces tat 
and env gene products. To produce the putative Rev protein, the splicing 
machinery uses the splice donor site within the leader sequence as well as the splice 
acceptor site at the end of pol to remove the gag and pol regions as previously 
discussed for the 3.2 kb mRNA. In addition, a splice donor site at the end of ORF 
SI is linked to a splice acceptor site just downstream of ORF S2. Finally, a donor 
site in env is linked to an acceptor site at the beginning of ORF S3. This creates a 
mRNA species containing the leader sequence linked to ORF SI, then to 
approximately 100 bp of env, and ORF S3. This multiply-spliced, 1.5 kb mRNA 
species is believed to produce both an intact Tat protein in addition to Rev. Two
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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additional species of viral mRNA have been identified in infected cells. One is 
multiply-spliced and similar to the mRNA that produces Tat and Rev but it lacks 
the first exon of rev. Therefore it is believed to produce only Tat. The other is a 
singly-spliced mRNA produced by the splicing of the leader sequence directly to 
the C-terminal portion of env. This mRNA produces a chimeric protein of 
unknown function, dubbed Ttm, encoded by the first exon of tat and the C-terminal 
portion of env (Derse et a l, 1993).
Tissue Tropism
EIAV infects peripheral tissue macrophages in vivo. Within chronically 
infected horses, viral antigen can be detected in lymph nodes, kidney, liver, lung, 
thymus, bone marrow, adrenal, stomach, pancreas, cerebrum, cerebellum, pituitary 
gland, and spleen. The highest concentrations are within the spleen, liver, lymph 
nodes, and bone marrow. All these tissues are enriched with peripheral 
macrophages. Hybridization studies indicate that viral antigen is localized to 
macrophage-like cells within these tissues. Analysis of viral DNA and in situ 
hybridization studies agree with this tissue distribution and localized viral mRNA 
to mature tissue macrophages exclusively (Sellon et al., 1994).
Sequence Variation
Like all retroviruses, EIAV isolates demonstrate a great degree of sequence 
divergence. In some cases, sequence divergence results in an altered phenotype and 
the creation of a new quasi-species or strain of the virus. Pair-wise sequence 
comparison between sequential EIAV isolates from an infected horse indicated a 
sequence variation as high as 1.43% overall. Much of this variation was localized 
to the env and LTR regions which, individually, showed sequence divergence rates 
as high as 5.6% (Payne et al., 1987). The high degree of sequence variation is
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believed to result from the error prone nature of the reverse transcriptase enzyme 
coupled to selective pressure by the immune system of the host. The retrovirus 
reverse transcriptase enzyme lacks any exonucleolytic proofreading activity and can 
have in vitro misincorporation rates as high as 1 in 1000 nucleotides. In addition, 
the unique nature of retrovirus replication, involving the transfer of nascent DNA 
strands to other locations in the genome, leads to a high degree of recombination 
and rearrangement. Although no exact measurement has been made of the 
frequency of these events, one study found that approximately 50% of HIV-1 
proviruses isolated from an individual contained some sort of sequence 
rearrangement such as a deletion, addition, or duplication. In many cases, these 
aberrations create unique viral phenotypes by changing the cytopathogenicity, 
tissue tropism, or replication capacity (Coffin, 1991).
In Vitro Propagation
Propagation of virulent EIAV field isolates in vitro is extremely difficult. 
Leukocyte cultures have a very short life-span, approximately 10 to 12 days, and 
,when infected with EIAV, can demonstrate rapid, within 72 hours post-infection, 
cytopathogenic effects. Due to this difficulty, Malmquist et al. (1973) adapted the 
Wyoming strain, a highly virulent field isolate, for growth in an equine dermis (ED) 
cell line. The ability to replicate in equine fibroblasts corresponded to a severe 
decrease in virulence. Subsequently, it was found that this Prototype strain was 
able to establish persistent, non-cytopathogenic infections in feline embryonic 
(FEA), fetal canine thymic (Cf2Th), and fetal equine kidney (FEK) cell cultures. 
The Prototype strain is also able to replicate in fetal donkey dermal (FDD) cells 
cultures but induces cytopathogenic effects within 22 days post-infection. Multiple 
passage of Prototype in FDD cell cultures led to a new virus strain, the FDD-
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adapted strain, which demonstrates cytopathogenic effects within 12 days post­
infection. Most recently, a number of EIAV molecular clones have been 
developed. Although infectious, none of these clones appear to cause disease 
(Sellon etal, 1994).
Cytopathogenicity
As little is known of retrovirus cytopathogenicity, the mechanism by which 
it occurs and the viral determinants that influence it are of considerable scientific 
interest. There are probably several different mechanisms by which retroviral 
infections can induce cell death and therefore the viral determinants that influence it 
may differ from one system to another. Experimental studies usually involve the 
exchange of gene segments between cytopathogenic and non-cytopathogenic 
strains. Numerous studies of this type have been performed on primate lentiviruses 
with very diverse results. Genetic regions that influence cytopathogenicity have 
been found throughout the lentivirus genome but are most often localized to the 
transmembrane, TM, and surface, SU, proteins produced by the env gene. The TM 
protein of retroviruses contains a membrane spanning region in its amino terminus 
that mutational analysis indicates is responsible for cell to cell fusion or syncitia 
formation in primate lentivirus infected cell cultures. In addition, the TM protein 
contains a region near its carboxyl terminus that may form an amphipathic helix. 
Should these helices aggregate within the plasma membrane and form channels, 
they would have a deleterious effect on the osmotic pressure across the plasma 
membrane. This theory explains why some cells infected with HIV demonstrate a 
large increase in cell volume prior to cell death. Studies performed with HIV 
strains containing deletions in the carboxyl terminus of the SU protein demonstrate 
syncitia formation but show an attenuation in the production of enlarged single
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cells (Garry, 1989). Not all cytopathic infections demonstrate the physical changes 
within the host cell required by the two previous theories. It has also been 
proposed that the HTV SU protein may induce programmed cell death or apoptosis 
in both T-cells and neural cells when bound in excessive amounts to the HTV 
receptor molecule CD4. This effect can be mimicked by incubation of these cell 
types with anti-CD4 antibodies (Gougen, 1993). The viral determinants of 
cytopathogenicity are not exclusively limited to the structural genes however.
Some cytopathogenic infections seem to be caused by an over-expression of the 
virus. There are examples of cytopathic HTV infections which produce an 
estimated 2.5x 106 copies of viral mRNA per cell or levels of viral protein as high 
as 40% of the cellular total. In these cases, it is possible that the cell is simply 
being overwhelmed by viral products resulting in a shutoff of host protein 
production and inevitable cell death. This situation is believed to occur when the 
host cell loses its resistance to super-infection (Garry, 1989). Most retrovirus 
infections lead to a down-regulation of the host protein that acts as the virus 
receptor which prevents a cell from being infected multiple times or super-infected. 
In studies with cytopathogenic avian retroviruses, excessive amounts of un­
integrated proviral DNA was found in the cytoplasm of infected cells indicating 
multiple rounds of viral infection. Subsequent experiments with UV irradiated 
virus capable of infection and reverse transcription but deficient in gene expression 
indicated that the presence of a large amount of viral proviral DNA was not, in 
itself, cytopathogenic. It is possible that super-infection of a host cell also leads to 
over-expression of viral mRNA or viral gene products causing cell death. The viral 
determinants which control the host cells resistance to super-infection are, once 
again, usually located within the env gene. Mutations in env may lead to a change
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in receptor recognition allowing the virus to circumvent the previous down- 
regulated receptor (Coffin, 1991).
The accelerated cytopathogenic effects induced by the FDD-adapted virus 
strain provides an interesting system for studying factors that influence virus 
cytopathogenicity. Perry et al (1992) examined the sequence differences between 
Wyoming strain proviral DNA, propagated in horse macrophage cultures, and the 
infectious molecular clone CL22, which is capable of replicating in ED cells and is 
not virulent. The results indicated that both the gag and pol regions were relatively 
conserved, with only 0.26% and 0.67% nucleotide difference respectively. Most of 
the sequence divergence occurred within the env and LTR regions. The surface 
protein, gp90, region of env showed a nucleotide difference of 5.57%, an amino 
acid difference of 11%, while the LTR indicated a divergence of 5.14% to 5.30%. 
These results are in approximate agreement with those obtained from other studies 
examining sequence changes upon tissue culture adaptation or disease progression 
within the host. These studies all agree that the LTR and env, including the S3 
ORF, are prone to a high degree of sequence variability. As gp90 is essential in the 
process of host cell recognition and attachment, it would seem logical that changes 
within this protein are necessary for any change in cell tropism such as tissue 
culture adaptation. Unfortunately, replacement of the CL22 gp90 coding region 
with the corresponding region from Wyoming strain proviral DNA resulted in a 
molecular clone still capable of infecting ED cells. Although this result was 
surprising, it seemed to agree with the data obtained on the FDD-adapted strain of 
EIAV.
In a previous study, the cytopathogenic infection of FDD cell cultures by 
FDD-adapted virus was compared to the persistent infection of FEK cell cultures
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by Prototype virus. Rasty et al. (1990) reported, as determined by 
immunofluorescence studies, that in the cytopathogenic infection approximately 
30% of the cell population was EIAV antigen positive while in the persistently 
infected cell culture almost 100% of the cell population exhibited EIAV antigen. 
This result was supported by data obtained by Southern hybridization analysis of 
total cellular DNA isolated from infected cultures. These results indicated 
approximately one third the amount of proviral DNA in the cytopathogenic 
infection relative to the persistent infection. Evidence indicated that the viral 
determinants which affect the cytopathogenicity of the FDD-adapted strain are 
probably not involved in cell recognition, attachment, or penetration of the virus as 
the percentage of cells infected in the cytopathic infection was actually less than 
that of the persistent infection and there was no accumulation of viral DNA 
indicative of super-infection. In addition, FDD cell cultures infected with the FDD- 
adapted virus did not demonstrate the morphological changes such as cell swelling 
or syncitia formation indicative of some cytopathic HIV infections. All this 
evidence seemed to discount the env region as the likely candidate responsible for 
the behavior of the FDD-adapted virus.
The study by Rasty et al. (1990) did reveal some possible explanations for 
the behavior of the FDD-adapted virus strain. Using Northern hybridization 
analysis, it was shown that FDD cell cultures infected with the FDD-adapted virus 
produced approximately 30 times as much viral mRNA as FEK cell cultures 
persistently infected with the Prototype virus. In addition, the cytopathogenic 
infection produced detectable levels of viral mRNA much earlier in infection. This 
was a very interesting result in light of some theories about the mechanism of 
retrovirus cytopathogenicity which indicate that the over-production of viral mRNA
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or viral gene products is cytotoxic. One region of the genome that directly 
influences the production of viral mRNA is the long terminal repeat.
Long Terminal Repeat
The most characterized lentivirus LTR is, of course, that of HIV. The HIV 
LTR contains a core enhancer/promoter region in its U3 region approximately 90 
nucleotides in length that is centered 65 bp upstream of the RNA cap site. This 
core unit contains the TATA box, two NF-kB and three SP-1 binding motifs and is 
essential for virus replication.
NF-kB is constitutively expressed in all mammalian cells yet plays a major 
role in restricting the replication of HTV to cell types involved in immune system 
functions such as T-lymphocytes and monocytes. Its level of expression is highest 
in B- and T- lymphocytes where it induces expression of the immunoglobulin k, 
interleukin-2a receptor, and interleukin-2 genes. In most cell types, including un­
activated T-cells, it is associated with an inhibitor protein, I-kB, which masks its 
nuclear localization signal causing it to be retained in an inactive state within the 
cytoplasm. T-cell activation leads to the phosphorylation and degradation of I-kB 
allowing NF-kB to migrate to the nucleus and stimulate transcription. A similar 
effect can be induced in other cell types by treatment with mitogens, cytokines, or 
other activating agents. In monocytes, NF-kB binding activity is induced by HIV 
infection itself. These elements are not necessary to maintain active viral 
replication of the virus in vitro but are required to activate transcription from the 
latent provirus.
Three tandem Sp-1 binding sites, which behave as proximal promoter 
elements, lie immediately downstream of the NF-kB sites. Although Sp-1 is a 
ubiquitous transcription factor and stimulates expression of a number of cellular
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genes, its expression is usually the highest in cells undergoing terminal 
differentiation. This protein contains a zinc-finger structural motif which 
recognizes DNA regions rich in GC dimers. Of the three Sp-1 binding sites, only 
the two sites proximal to the HTV promoter are active. It is essential for viral 
replication that one of these two binding sites be maintained and in close proximity 
to the TATA box as Sp-1 interacts directly with TATA box binding protein 
associated factor 110. It has been suggested that Sp-1 acts to stabilize pre-initiation 
complexes. The complete absence of these sites eliminates promoter activity under 
both basal and transactivated conditions. Sp-1 is also capable of interacting in a 
synergistic manner with other transcription factors bound to more distal elements 
such as NF-kB, Ets-1, or additional Sp-1 monomers.
Approximately 24 bp upstream of the transcriptional start site is the HTV 
TATA box. Similar to other eukaryotic promoters, the HIV TATA box binds the 
TATA box binding protein (TBP) component of transcription factor IID (TFIID) 
and provides the location for the assembly of the RNA polymerase II complex. The 
actual role of the TATA element is somewhat more complex however as mutations 
within this region that do not effect basal transcription can dramatically reduce 
transactivation by Tat. In addition, mutations within this region that do reduce 
basal transcription can be corrected for by corresponding mutations within the Sp-1 
sites. These experiments strongly suggest interactions between the RNA 
polymerase complex at the TATA box and both Sp-1 and Tat. The TATA box of 
HIV is flanked on both sides by palindromic E box motifs (CANNTG) which have 
also been shown to bind cellular proteins that stabilize the TFIID complex while 
displacing TBP. Mutations within these motifs effect transcription under both basal 
and transactivated conditions.
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Overlapping the TATA region is the initiator element or SSR (start site 
region). Originally identified in the terminal deoxynucleotidyl transferase gene, 
this element allows the initiation of transcription in the absence of a TATA box. 
The RNA polymerase complex formed on this element differs from the complex 
formed at the TATA box in that it does not respond to transactivation by Tat. This 
complex has only been demonstrated in vitro.
Downstream of the transcription start site, nucleotides +1 to +59, is the 
TAR element of HTV-1. TAR forms a stem-loop structure in nascent viral RNA 
that is essential for viral replication and is both proximity and orientation 
dependent. The actual structure rather than the sequence is most important for 
activity although the nucleotides comprising the loop are important as is a uracil 
residue within a three nucleotide bulge on the stem region. It is this bulge that 
actually binds the viral protein Tat while the loop region is known to bind a variety 
of other cellular factors. Competition studies show that TAR DNA fails to inhibit 
Tat recognition of TAR RNA thereby proving that TAR functions primarily as an 
RNA element. The exact mechanisms by which the Tat/TAR complex acts to 
enhance viral expression could involve both transcript elongation and initiation. In 
the absence of Tat, the HIV-1 promoter produces a large amount of short transcripts 
comprising only the region between the transcription start site and TAR. This 
region has been named 1ST for inducer of short transcripts and mutations within 
this region interfere with short transcript accumulation. In the presence of Tat, the 
number of short transcripts decreases and longer viral RNA transcripts 
predominate. Experiments have also shown that Tat is able to modify transcription 
factor complexes artificially stalled at TAR allowing them to elongate. Both of 
these observations indicate that the Tat acts to elongate stalled HIV-1 transcripts
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probably through interactions with transcription factors TFIIF and TFIIS. 
Presumably, TAR simply acts to bind Tat and bring it into close proximity with the 
HIV promoter. Other studies indicate that Tat may stimulate transcription initiation 
as well. Mutations mapping to the TATA or Sp-1 binding regions can influence 
transactivation without influencing basal transcription. These synergistic 
interactions between upstream elements and Tat may implicate it in transcription 
complex assembly. Therefore, Tat may act to stimulate transcription initiation as 
well as elongation.
The remainder of the U3 region (upstream of the core region) contains an 
array of possible transcription factor binding sites such as those for, LEF, Ets-1 or 
Ets-2, and AP-1. Mutational analysis of these sites often yield variable results 
depending on cell type and, in some cases, these sites negatively regulate 
transcription. Therefore the relevancy of these sites is still controversial. It has 
been speculated that these sites confer responsiveness of the LTR to diverse cellular 
signals allowing for changes in cellular tropism (Antoni et al., 1994; Garcia and 
Gaynor, 1994; Gaynor, 1995; Jones and Peterlin, 1994).
Of the transcriptional activators that bind to elements upstream of the core 
enhancer/promoter region, one of the most interesting may be the lymphoid 
enhancer factor 1, LEF-1. Identified in human T- and B- cells, this factor does not 
seem to enhance transcription itself but acts synergistically with other enhancer 
elements in close proximity such as the Ets-l site. LEF binding induces a bend 
within the DNA of 110°. This is believed to facilitate the protein-protein 
interactions between upstream enhancer elements and proximal promoter elements 
such as Sp-1. In support of this mechanism, a minimum distance is required
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between LEF and the promoter as deletion of the intervening DNA abrogates LEF 
function (Giese et al., 1992; Jones and Peterlin, 1994).
Ets-1 is a member of the proto-oncogenic ets family of transcription factors 
which includes Ets-1 and 2, PU.l, Spi-l, Elf-1, PEA3 and others. Members of this 
family have been linked to a variety of steps involved in hematopoeisis especially 
myeloid and lymphoid cell specific gene expression. PU.l, for example, up- 
regulates the production of the macrophage colony stimulating factor receptor and 
the macrophage scavenger receptor during macrophage differentiation. Another 
family member, Elk-1, binds to the serum response element upstream of c-fas. 
Little is known about the mechanisms by which these proteins are regulated. 
During B-cell activation, phosphorylation of Ets-1 by caseine kinase II results in its 
release from the DNA. In T-cells however, Elf-l is sequestered by the under- 
phosphorylated form of the retinoblastoma protein, Rb. Upon T-cell activation, the 
phosphorylation of Rb leads to the release of Elf-1 allowing it to activate 
transcription. These proteins are believed to contain helix-tum-helix structural 
motifs which interact with the DNA. The minimal consensus core sequence 
recognized by these factors is C/A GGA A/T but nucleotides in proximity to the 
core motif may influence exactly which factor binds to a given site as multiple 
members of the ets family may be present within the same cell type. However, in 
the case of the immunoglobulin heavy chain enhancer, multiple ets proteins are 
capable of binding at the same recognition site. Ets recognition sites are often 
found in multiples and in close proximity to other transcription factor binding sites, 
such as those for AP-1 and Sp-1, with which they often act in synergy. In the 
HTLV-1 LTR, Ets-1 or Ets-2 interact cooperatively with Sp-1 to activate 
transcription. Combinatorial interactions between ets proteins and AP-1 have been
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demonstrated to activate transcription of polyoma virus, granulacyte-macrophage 
colony stimulating factor, and the macrophage scavenger receptor (Jones and 
Peterlin, 1994; Moreau-Gachelin, 1994; Wang et al., 1994; Wu et al., 1994).
AP-1, originally human activating protein I, is a transcription factor formed 
primarily from the products of the c-fos and c-jun proto-oncogenes. AP-1 protein 
complexes are usually Fos/Jun heterodimers but may also consist of Jun/Jun 
homodimers. Both Fos and Jun contain a leucine zipper motif flanked by basic 
residues which form the region where protein dimerization and DNA binding occur. 
Similar motifs are found in other transcription factor families such as ATF, CREB, 
and the glucocorticoid receptor. Due to this similarity, Fos and Jun are capable of 
forming complexes with these proteins as well. Although the consensus 
recognition sequence for AP-l is TGACTCA, the heterogeneous nature of the 
protein complex itself and the influence of surrounding nucleotides leads to a large 
degree of variability in AP-1 recognition sites and its effect on transcriptional 
activity. AP-l complexes, in conjunction with the glucocorticoid receptor, can 
actually inhibit transcription of the proliferin gene. AP-l activity in cell cultures 
may be temporarily induced by treatment with protein kinase C activators such as 
phorbol esters but its regulation on the cellular level is much more complicated than 
its state of phosphorylation as both fos  and jun  are auto-regulatory and affect the 
expression of several other transcription factors (Kerppola and Curran, 1991).
At the time this study was initiated, very little was known about the 
transcription factor complexes formed by the EIAV LTR. Compared to other 
lentiviruses, it is quite short with a U3 region of approximately 200 bp, an R region 
of approximately 80 bp, and a U5 region approximately 40 bp long. The average 
length of a lentivirus U3 region is 450 bp, the R region 100 bp, and the U5 region
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70 bp in length (Coffin, 1991). The short length of the U3 region, where most ex­
acting regulatory signals are usually confined, indicated that the transcription 
factor-LTR complexes formed in the case of EIAV were probably fewer in number 
relative to complex lentiviruses such as HTV. Derse et al. (1987) performed a 
functional comparison of two different LTR variants isolated from proviral DNA. 
They identified the putative TATA box and poly-adenylation signals based on 
sequence analysis and identified the RNA cap site by SI nuclease mapping. In 
addition, they replaced the SV40 promoter sequences of the CAT expression vector 
pSV2/CAT with the LTRs and quantitated their transient expression levels in a 
variety of cell lines. The results of this study indicated that the EIAV LTRs were 
very weak promoters relative to the SV40 virus promoter in all the cell lines tested 
but their activity was greatly enhanced, by over 200 fold, when the cell cultures 
were infected with EIAV. This was the first evidence that EIAV produces a 
product which transactivates its LTR. In a following study, Sherman et al. (1988) 
used deletion mutants of the LTR coupled to the CAT gene to demonstrate that 
deletion of the U5 and R regions abrogated transactivation in a Cf2Th cells. The 
transactivation response element was further localized by deletion studies in FEA 
cells to the R region (Dorn and Derse, 1988). More recent studies have since 
identified the TAR element of EIAV as a stem-loop structure formed by 
nucleotides +1 to +25. Similar to HIV-1, EIAV Tat interacts with an RNA element 
and requires additional cellular factors such as Tat associated protein kinase TAK 
(Herrmann, 1995; Derse et al., 1993). Although much work was performed 
identifying the TAR and tat regions of the genome, very little attention was given 
to identifying the basal transcriptional complexes formed by the LTR. In FEA cell 
cultures, progressive deletions indicated that sequences upstream of position -111
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were dispensable for basal promoter activity. Deletion of an additional 35 bp 
produced an LTR mutant almost twice as active as the un-modified version 
indicating the presence of a negative regulatory element. Further removal of 
sequences to positions -41 or -31 resulted in mutants whose promoter activities 
were only about half the original while deletion of regions downstream of the 
transcriptional start site had no significant effect (Dorn and Derse, 1988). These 
results were similar to those obtained by a study of LTR deletion mutants in Cf2Th 
cells. This study also showed that regions downstream of the cap site were 
dispensable for basal transcription and that deletion of U3 sequences upstream of 
position -50 removed a negative regulatory element and created a deletion mutant 
with a much stronger promoter activity than the original LTR (Sherman et al.,
1989).
During the course of this investigation, several studies were published 
which identified putative transcription factor binding sites in the EIAV LTR. These 
studies were performed in canine osteosarcoma (D17), human epithelial carcinoma 
(HeLa), human monocytic (U937 and THP-1), equine fibroblast (equine 6288), and 
human B-cell (Raji) cell lines as well as primary horse mononuclear cell cultures 
(PBMC). Using an LTR isolate derived from a non-infectious proviral DNA clone 
of EIAV, XI2, Carvalho and Derse (1993a) identified four regions protected from 
DNase 1 digestion by D17 nuclear extracts. Three protected regions are upstream, 
but within 100 base pairs, of the transcription start site while the fourth region is 
immediately downstream.
Based on recognition site homology, the first protected region (nucleotides - 
98 to -86) was believed to overlap with a binding site for the methylated DNA 
binding-protein (MDBP). This conclusion was supported by subsequent
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
29
electrophoretic mobility shift assays (EMSA) using D17, Raji, and THP-1 nuclear 
extracts. The protein-DNA complexes formed by the extracts were inhibited by the 
addition of an oligonucleotide containing a previously characterized MDBP binding 
element. In addition, deletion of sequences upstream of nucleotide -76 reduced 
promoter activity 38% and 58% in D17 and HeLa cells respectively, using transient 
gene expression assays. Subsequently, MDBP has been shown to be an isoform of 
histone protein HI (Bruhat and Jost, 1995; Jost and Hofsteenge, 1992). This may 
reconcile this study with those previous in which a negative regulatory element was 
identified. The complete assembly of histone complexes would depend upon 
cellular conditions and could inhibit initiation of transcription from the LTR.
The second protected region (nucleotides -81 to -60) was postulated to 
contain two polyomavirus enhancer A factor 2 (PEA2) binding elements (Carvalho 
and Derse, 1993a). The protein which recognizes this element is a member of the 
same family of transcription factors as the Caat box binding protein (Merriman et 
al., 1995). An oligonucleotide containing these elements formed protein-DNA 
complexes with D17, equine 6288, and THP-1 but not with HeLa and Raji nuclear 
extracts. Formation of these complexes was inhibited by co-incubation with an 
oligonucleotide based on LTR nucleotides 2 to 27 which is the fourth protected 
region. Therefore, the binding element contained within nucleotides 2 to 27 is also 
a putative PEA2 binding site. Deletion and mutation analysis indicate that the 
second protected region behaves in a complex manner. Mutation of each site 
individually, PEAmutl and PEAmut2, resulted in no change in promoter activity in 
D17 cells while PEAmut2 reduced activity by 75% and PEAmutl increased activity 
by 170% in HeLa cells. Complete deletion of both sites (nucleotides -76 to -63) 
reduced activity by 40% in D17 cells, 50% in THP-1 cells and by 95% in HeLa
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cells. The conclusions drawn from these results is that this region is very important 
for promoter activity but that different element(s) within or overlapping this region 
are active depending upon the cell line used. The identification of the active 
elements as PEA2 sites remains, at best, inconclusive.
The protected region in closest proximity to the TATA box contains, or is 
adjacent to, three putative binding motifs: AP-1, PU.l and Oct. This region as a 
whole was found to confer TPA responsiveness upon the LTR. Mutation of the 
AP-1 motif (nucleotides -45 to -60) reduced promoter activity by 86%, 50%, and 
95%, in D17, THP-1 and HeLa cells respectively. Nuclear extracts prepared from 
D17 cells formed a protein-DNA complexes with an oligonucleotide based on LTR 
nucleotides -40 to -67. Formation of this complex was only partially inhibited by 
the addition of a competitor oligonucleotide containing a consensus AP-1 site 
raising the possibility that this site binds different AP-1 heterodimers or multiple 
transcription factors. The second half of this protected region was postulated to 
contain a putative Oct motif overlapping a PU. 1 recognition element. Mutation or 
deletion of this PU.l element reduced promoter activity by 80% or 51%, 
respectively, in D17 cells whereas promoter activity was completely abolished in 
HeLa and THP-1 cells. An oligonucleotide corresponding to LTR nucleotides -30 
to -58 was found to form a complex pattern of protein-DNA complexes with D17 
cell extracts. Competitor oligonucleotides containing either an Oct or a PU.l 
recognition element were able to change the mobility shift pattern formed by LTR 
oligonucleotide -30 to -58. On the basis of this data, it was postulated that in the 
absence of PU.l, Oct could bind the vacated element (Carvalho and Derse, 1993a). 
In a following study, Carvalho and Derse (1993b) showed that formation of 
protein-DNA complexes with an oligonucleotide based on LTR nucleotides -35 to -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
46 by THP-1 and U937 cell extracts was abolished by pre-incubation with an 
antiserum raised against PU.l and that PU.l expression by HeLa cells stimulated 
transcription from the LTR by 10 fold. The definitive study of the PU.l element 
was performed by Maury (1994) who utilized horse monocyte cell cultures and an 
LTR isolate, derived from the macrophage cultures infected with the Th-1 field 
isolate of EIAV, which contained three possible PU.l, an AP-1, and a PEA2 
binding motifs. The maturation of the horse monocyte cell cultures was controlled 
by the withholding or the addition of adult horse sera. Mobility shift assays 
demonstrated that cultures which were allowed to mature to adherent macrophages 
formed pronounced DNA-protein complexes with the three PU.l motifs of the LTR 
but none with possible AP-1 and PEA2 motifs. Cultures held as monocytes did not 
form these complexes at readily detectable levels. This study also showed that the 
complexes formed at the PU.l sites were super-shifted by the addition of antiserum 
against PU.l but not when incubated with serum against Ets-1 or Ets-2 
transcription factors. Interestingly, mutation of all three possible PU.l binding sites 
did not result in a drop in promoter activity under basal conditions, but eliminated 
transactivation by EIAV Tat. Therefore, PU.l may directly interact with EIAV Tat. 
Although there are a great many curious or contradictory results in all these studies, 
it seems likely that provirus transcription in macrophages is controlled primarily 
through the expression and subsequent binding of PU.l.
Sequence variations in the LTRs of retrovirus isolates are a common 
phenomena and, in some cases, result in dramatic changes in the transcription factor 
binding motifs discussed previously. Deletion, modification, or insertion of 
recognition sites has been shown to affect in vitro promoter strength and replication 
capacity of the virus (Carvalho et al., 1993). It has often been proposed that these
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sequence variations could influence the disease causing potential of different virus 
isolates by influencing replication capacity or cellular tropism in vivo (Clements 
and Payne, 1994).
The effects of LTR modification on virus phenotypes is well documented in 
several oncovirus systems. Rous-associated virus (RAV) is a non-acute oncovirus 
found in chickens. RAV-0 is benign whereas RAV-1 infection induces lymphoma 
and a variety of neoplasms. By exchanging regions of a pathogenic proviral RAV- 
1 clone with corresponding regions from RAV-0 proviral DNA, it was found that 
the primary determinant of disease causing potential mapped to the 5' LTR region 
(Brown et al., 1988). In a different study, investigators used the polymerase chain 
reaction technique to amplify Feline leukemia virus proviral DNA from cats with 
benign infections and from cats with thymic lymphomas. U3 sequences amplified 
from tumor cells showed considerable sequence divergence from the parent strain 
used for inoculation and 50% had sequence duplications of the core enhancer 
region. A survey of U3 sequences from benign infections showed few differences 
from the parental strain (Rohn and Overbaugh, 1995). Numerous experiments 
performed with murine leukemia viruses indicate that their long terminal repeats 
also confer tissue selectivity. Recombinant viruses with an LTR derived from a 
virus which causes T-cell leukemia preferentially infected the thymus while the 
same provirus backbone with an LTR derived from a virus which causes 
erythroleukemia preferentially infected spleen and bone marrow (Rosen et al., 
1985). Of course, these examples all involve oncovirus systems in which the 
primary pathological effect is cell transformation. Two mechanisms by which 
oncoviruses induce transformation of the host cell, over-production of an adjacent 
cellular gene or production of a viral oncogene, are directly dependent upon the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33
promoter strength of the viral LTR. The affects of LTR variability on the behavior 
of lentiviruses is more difficult to discern as diversity in structural or regulatory 
gene products are most often responsible for changes in phenotype. In a study by 
Englund et al. (1991), three HIV-1 molecular clones isolated from a single virus 
stock demonstrated different replication kinetics and cytopathogenicity when 
propagated in a human T-cell line. The molecular clone which produced reverse 
transcriptase activity the most rapidly also caused the most rapid and severe loss of 
host cell culture viability. The viral determinant for this behavior was subsequently 
mapped to the LTR which was found to contain a 14 bp sequence insertion that 
created a third NF-kB recognition motif. The basal promoter activity of this LTR 
was subsequently found to be approximately four times as great as that of the LTRs 
from the two remaining molecular clones. To demonstrate the influence of the 
LTR on cellular or tissue tropism, transgenic mice were created which contained an 
HIV-1 pro virus under the control of LTRs derived from infected neurons or from 
infected T-cells. Mice containing LTRs derived from neurons showed viral 
replication in their central nervous systems while mice containing T-cell tropic 
LTRs did not (Corboy et al., 1992). Thus the LTR region of retroviruses can play a 
very important role in tissue tropism which, in turn, can influence disease outcome.
Similar to other lentiviruses, the U3 region of the EIAV LTR demonstrates 
a high degree of sequence variability. Analysis of viral cDNA isolated from 
sequential disease episodes of a pony experimentally infected with a pathogenic 
isolate of EIAV demonstrated a nucleotide divergence rate for the LTR as high as 
5.6% compared to a 1.43% divergence overall. In addition, analysis of proviral 
DNA isolated from horse peripheral blood mononuclear cell cultures (PBMCs) 
infected in vitro yielded a similar result, a nucleotide divergence rate for the LTR as
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high as 8.4% between two different virus stocks (Carpenter et al., 1991). Both 
these studies also indicated that the majority of the sequence divergence was 
localized to a hypervariable region centered approximately 60 bp upstream of the 
TATA box which was prone to imperfect sequence duplications. These 
duplications resulted in the insertion o f an additional 20 to 28 bp and the creation of 
LTR sequence variants. These insertions may duplicate or create transcription 
factor binding sites thereby changing the promoter activity of the LTR.
In a recent study, Carvalho et al (1993) examined the behavior of variant 
LTR isolates, amplified from FEA cell cultures persistently infected with EIAV, in 
U937, HeLa, and D17 cells. All these isolates contained sequence insertions in the 
hypervariable region that created additional AP-1, Oct, and/or PU.l binding sites. 
Transient expression assays demonstrated that the LTR variants behaved differently 
from cell line to cell line. In U937 cells, the putative AP-1 duplication actually 
seems to inhibit promoter activity while successive duplications of the PU.l motif 
increase it. In HeLa cells, additional PU.l and/or AP-1 motifs result in increased 
activity while neither duplication has any discernible effect on activity in D17 cells. 
Only the creation of an Oct site results in an increase in basal promoter activity. It 
was speculated that these LTR variations may influence disease outcome similar to 
what occurs in other lentiviral systems.
Research Objectives
The goal of this dissertation research was to examine the influence of EIAV 
LTR variability on promoter activity, replication kinetics, cytopathogenicity, and 
tissue tropism. The specific research objectives are: (1) isolation and sequence 
analysis of multiple variant LTR isolates; (2) measurement of variant LTR 
promoter strength by transient gene expression in cell cultures; (3) deletion analysis
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of the LTR variant exhibiting the highest promoter activity; (4) quantitation of 
variant LTR sequences in DNA isolated from infected horse tissues using 
competitive PCR; and (5) placement of an LTR variant in an infectious proviral 
clone and examination of its replication kinetics and cytopathogenicity by 
measurement of cell culture proliferation, reverse transcriptase activity, viral 
mRNA and viral DNA production, and immunofluorescence.
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CHAPTER 2 
MATERIALS AND METHODS 
Virus Strains and Cell Cultures
Fetal donkey dermal (FDD), canine fetal thymic (Cf2th), and feline 
embryonic (FEA) cell cultures were maintained in Eagle's minimum essential 
media (MEM) (Sigma) supplemented with 10% fetal calf sera (Atlanta Biologicals) 
and 50 ug/ml Gentamycin (Sigma). FDD-adapted EIAV (AFDD) was obtained by 
sequential passage of Prototype virus in FDD cultures 27 times.
Preparation of Total Cellular DNA from Infected FDD Cultures
FDD cell cultures, infected with AFDD, were washed and harvested 6 days 
post-infection with phosphate buffered saline (PBS) solution-10 mM EDTA 
(PBSE). Cells were re-suspended in 10 mM Tris-HCl (pH. 8.0), 100 mM NaCl, 
0.025 mM EDTA (pH 8.0), 0.1 mg/ml Proteinase K, 0.5% SDS, and incubated at 
55°C overnight. The lysate was subjected to phenol and phenol/chloroform 
extractions followed by ethanol precipitation and centrifugation. The pellet was re- 
suspended in 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 50 mM NaCl, 20 ug/ml 
RNase A, and incubated at 37°C for one hour. The solution was extracted with 
phenol/chloroform and ethanol precipitated sequentially in the presence of 2.5 M 
NH4AC to remove free nucleotides. The air dried DNA pellet was re-suspended in 
TE buffer (pH 7.6) at 50°C overnight and quantitated spectrophotometrically. 
Amplification, Cloning, and Sequencing of AFDD LTR
The 3' LTR was amplified by the polymerase chain reaction using the 
primer pair ->ALTR5 Y5 '-ATTATGAAGCTTATGTATCAATGC CTCA-3 '1 and <- 
ALTR3 '(5’-ATAATCCAGCTCTAGGATCTCGAACA-3') which contain the 
restriction enzyme sites Hindlll and Pvull respectively. The amplification reaction
36
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was performed in 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (N H ^ S O ^  
0.1% Triton X-100, 6 mM MgSC>4, 200 uM dNTPs, 2 uM primers, 0.5 ug template 
DNA, and 2 units Vent (exo-) polymerase (New England Biolabs) at 94°C 1 
minute, and 60°C 30 seconds for 35 cycles. The reaction product was digested with 
Hindlll and Pviill restriction endonucleases and ligated into ///«dIII/£coRV 
digested pBluescript II KS+ (Stratagene) to form pALTR/Blue constructs. Clones 
were screened by sequencing using the dideoxy method as recommended by the 
manufacturer (United States Biochemical). Sequence comparison and alignment 
were performed using UWGCG software package. The sequence of AFDD LTR 
clone 3 (ALTR3) was numbered relative to the putative transcription start site 
previously identified for the LTR of EIAV molecular clone A. 12 (Derse et al.,
1987).
Construction of LTR/Reporter Vectors
The pLTR/CAT expression vector, containing the 5' LTR of molecular 
clone A. 12 upstream of the chloramphenicol acetyl transferase (CAT) gene of 
pSVO/CAT, was provided by Dr. Louis Schiltz. For purposes of clarity, this LTR 
sequence will be referred to as Prtt and the construct pPrtt/CAT. Variant LTRs 
from sequential horse isolates p3.2-l, p3.2-3, and p3.2-5 were obtained as 
Sspl/Dral fragments of viral cDNA ligated into the multiple cloning region of 
Hincll digested pUC13. These constructs were provided by Dr. Keith Rushlow.
The LTR variants were removed as HindllllMlul fragments and ligated with 
MluUBamEl and BamWHindlll vector fragments derived from pPrtt/CAT (Fig. 3). 
The constructs produced (p3.2-1/CAT, p3.2-3/CAT, and p3.2-5/CAT) contain 
variant U3 sequences upstream of the Mlul site, which includes the hypervariable 
region, with the remainder of the LTR being identical to Prtt. ALTR3 and ALTR4
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Figure 3. Block diagram of the EIAV LTR. The relative locations of restriction 
enzyme sites used in molecular cloning are indicated for the EIAV LTR in the 
context of the pPrtt/CAT construct (Panel A) and the molecular clone pSPEIAV44 
(Panel B).
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were removed and gel purified from pBluescript II KS+ and placed into 
Hindlll/Stul digested pPrtt/CAT to form pALTR3/CAT and ALTR4/CAT. The 
constructs contain variant sequences upstream of the Stul site. The cognate LTR 
(PV44) of the infectious molecular clone pSPEIAV44 (Payne et al., 1994) was 
obtained as an SpeVMlul fragment cloned into XbaUEcoRl digested pUC13. The 
LTR was removed as a HindllUMlul fragment and ligated with MlullBamHI and 
BamHUHindlll fragments of pPrtt/CAT to form pPV44/CAT. This construct 
contains PV44 sequences upstream of the Mlul site and Prtt sequences downstream. 
Site-directed mutagenesis was used to create an Xhol site within the U3 region of 
ALTR3. This facilitated the cloning of ALTR3 into an infectious EIAV clone. The 
creation of A3(A7zoI)/Alt is outlined in another section. The LTR mutant was 
removed from this construct as a HindllllHindlll fragment and placed into Hindlll 
digested pSVO/CAT to form A3(A7?oI)/CAT. LTR fragments obtained by digestion 
of pPrtt/CAT, pALTR3/CAT, p3.2-l/CAT, and p3.2-5/CAT with Hindlll were gel 
purified and cloned into Hindlll digested pGL2-Enhancer (Promega) luciferase 
reporter vector to generate pPrtt/Luc, pALTR3/Luc, p3.2-1/Luc, and p3.2-5/Luc.
All clones were verified by restriction digestion.
Deletion Mutagenesis of pPrtt/CAT
The LTR fragment that results from HindlHJAlul digestion of Prtt, 
containing U5, R, and U3 sequences downstream of the Alul site, was modified 
with a synthetic Mndlll linker and subsequently inserted into Hindlll digested 
pSVO/CAT to form pD(//mdIIIA4M)/CAT. A construct which contains no U3 
sequences upstream of the Alul site. The deletion mutant pD(zl/wI///z>jcII)/CAT 
was created by joining a PstUAlul fragment, containing the first 94 base pairs of 
U3, to a HinclUEcoRl fragment, containing U5, R, some U3 sequences, and a
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portion of the CAT gene, which had been inserted into Hincll/EcoRl digested 
pUC13. The LTR sequences were removed from this intermediate as a Hindlll 
fragment and inserted into Hindlll digested pSVO/CAT. This construct is missing 
the hypervariable region and flanking sequences. Products were screened by 
restriction enzyme digestion and verified by sequencing.
Construction of ALTR3/Luc Mutants.
Deletion mutants were derived from pALTR3/Blue using a primer directed 
method. In brief, this procedure uses a pair of primers, which flank the region to be 
deleted, to amplify the remainder of the LTR and the entire vector to produce a 
linear molecule which is subsequently re-ligated and propagated within a bacteria 
host. Reactions were performed in 20 mM Tris-HCl, 10 mM KCI, 10 mM 
(NH4)2SC>4, 0.1% Triton X-100, 6 mM MgS04, 200 uM dNTPs, 1-2 uM primers,
2 ng template DNA (pLTR3/Blue), and 2 units Vent (exo+) polymerase at 94°C 2 
minutes, 62°C 1 minute, and 72°C 3 minutes for 25 cycles. Products were screened 
by sequencing and correct mutant LTR sequences were excised from pBluescript II 
KS+ with Kpril/Sacl and inserted into the pGL2-Enhancer vector similarly digested. 
Primer pairs used and their deletion products are described in Table 2.
Transfection of FDD Cell Cultures
Transfections were performed using the calcium phosphate precipitation 
technique. All plasmid DNA was purified by large scale alkaline lysis followed by 
centrifugation in CsCl/ethidium bromide density gradients. Ethidium bromide and 
cesium chloride were removed by four butanol extractions and two ethanol 
precipitations respectively. Purified DNA was quantitated spectrophotometrically. 
FDD, Cf2th, and FEA cells were plated at a density of approximately 2x 10^ cells 
per well in 6 well (35 mm) culture dishes and allowed to grow for 24 hours. Cells
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were washed once with serum-free MEM media and re-fed with 3 mis fresh growth 
media prior to transfection. A 0.250 M CaCl2 solution (0.150 ml) was mixed with 
3 ug LTR reporter vector, 6 ug pSV/p-Gal (Promega), and I ug pBluescript DNA 
in the case of basal conditions or 3 ug LTR reporter vector, 6 ug pSV/p-Gal, and 1 
ug pSV/720 DNA (an EIAV Tat expression plasmid) in the case of transactivated 
conditions. A 280 mM NaCl, 50 mM HEPES, and 1.5 mM Na2HP04-7H20 
solution (HBS) (pH 7.1) (0.150 ml) was added drop-wise under a stream of 
nitrogen gas. The solution was incubated at room temperature for 15 minutes and 
then added drop-wise to the appropriate tissue culture well. Transfection was 
allowed to proceed for 6 hours followed by a serum free media wash, a 3 minute 
glycerol shock (15%), a serum free media wash, followed by the addition of 3 mis 
of growth media. Cells were harvested for CAT assay 48 hours post-transfection 
by washing and harvesting in PBSE followed by one wash in regular PBS.
Deletion Construct
Table 2. Primer pairs and their deletion products.
Primer Pair
<—LTRP1: 5'-C ATACTGAGGC ATT GATAC AT-31
-*LTRP2: 5’-AAATGATTATAAGAGTAAAAAGAA-3' pD(-233/-185)/Luc
<—LTRP3: 5'-TTTATAAAACCCCTCATAAAAAC-3'
->LTRP4: 5'-ATAACCCAAAGGACTAGCTCA-3'
<-LTRP5: 5'-AGGTTATGAGAGCATCAGCAA-3'
->LTRP6: 5'-CTCATGTTGCTAGGCAACTAA-3'
<—LTRP7: 5'-CTAGTCCTTTGGGTTATGCA-3'
—>LTRP8: 5-CTAAACCGCAATAACCGCAT-3'
pD(-181/-135)/Luc
pD(-137/-118)/Luc
pD(-117/-101)/Luc 
table con’d
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4-LTRP9: 5'-GTTAGTTGCCTAGCAACATGA-3' 
->LTRP10: 5'-CCGCATTTGTGACGCGAGTT-3'
<—LTRP11: 5 '-GTTATTGCGGTTTAGTTGCCAT-3' 
-»LTRP12: 5'-TGTGACGCGAGTTCCACATTT-3' 
<-LTRP13: 5'-CAAATGCGGTTATTGCGGTT-3' 
-+LTRP14: 5'-TTGTGACGCATTTAACTTCCT-31 
<-LTRP15: 5'-CAAATGTGGAACTCGCGTCA-3' 
-»LTRP16: 5'-CCTGTTTTTAC AGT AT AT AAGT G-3' 
<—LTRP17: 5'-TAAATGCGTCACAAATGTGGAA-3' 
-»LTRP18: 5'-GTAT AT AAGT GCTTGTATTCT G A-3' 
<-LTRP19: 5’-CCGATTGTCAGAATACAAGCA-3' 
->LTRP20: S'-CTTCTCTGCTGGGCTGAAA^’ 
<-LTRP21: 5-AGAAGGGACTCAGACCGCA-3' 
-►LTRP22: 5'-GTTTGTCTGTTCGAGATCCTA-3'
pD(-94/-87)/Luc
pD(-85/-80)Luc
pD(-77/-61)Luc
pD(-57/-43)Luc
pD(-46/-31)Luc
pD(l/26)Luc
pD(32/90)Luc
Chloramphenicol Acetyl Transferase and Luciferase Enzyme Assays
CAT assays were performed by the acetyl-chloramphenicol diffusion 
method (Neuman et al., 1987). Cell pellets were re-suspended in 100 mM Tris 
buffer (pH 7.8) and subjected to three rounds of rapid freeze-thawing in a dry ice, 
ethanol bath. Insoluble cellular debris was pelleted by centrifugation (12,500xg) at 
4°C for 5 minutes. The supernatant (0.050 ml) was heated to 70°C for 15 minutes, 
mixed with 0.200 ml o f a 1.25 mM chloramphenicol (Sigma), 100 mM Tris (pH 
7.8) and 0.02 uCi [^ C ] butyryl coenzyme A (Dupont-NEN) solution. This 
solution was transferred to a 7 ml liquid scintillation counting (LSC) vial, overlaid
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with 5 ml Econofluor LSC fluid (Dupont), and counted in a Beckman LSC 6000 
after 16 hours at 37°C. Values represent CPM per uU P-galactosidase and an 
average of at least three trials. Luciferase assays were performed as recommended 
by the manufacturer. FDD cell pellets were re-suspended in 0.200 ml reporter lysis 
buffer and subjected to two rounds o f rapid freeze-thaw. Cellular debris was 
removed by centrifugation (12,500xg) at 4°C for 5 minutes. The supernatant 
(0.005 ml) was diluted to 0.020 ml with reporter lysis buffer, mixed with 0.100 ml 
luciferase assay reagent, incubated 1 minute, and counted in a Beckman LSC 4000 
in single photon counting mode. Values represent CPM per nU P-galactosidase and 
an average of at least three trials. P-galactosidase activity was measured by mixing 
0.015 ml of cell lysate with 0.300 ml of a 100 mM sodium phosphate (pH 7.5), 1 
mM MgCl2, 45 mM p-mercaptoethanol, and 2.2 mg/ml o-nitrophenyl-P-D- 
galactopyranoside solution at 37°C for 16 hours and measured by 
spectrophotometric quantitation at 420 nm as outlined in Sambrook et al. (1989). 
All mean values were analyzed for statistical significance using the Kruskal-Wallis 
one way analysis of variance based on ranks and Dunnetts method of pairwise 
comparison.
Insertion of ALTR3 into an Infectious Clone
The LTR regions of the infectious proviral clone pSPEIAV44 and AFDD3 
were separately inserted into the mutagenesis vector pALTER-1 (Promega). The 
proviral LTR was removed as an NruUBambO. fragment, which contains the entire 
3' LTR and part of the env gene, and inserted into SmallBamHl digested pALTER- 
1 to form pPV44/Alt (Fig. 3). Likewise, ALTR3 was removed from pALTR3/CAT 
as a Hindlll fragment and inserted into the Hindlll site of pALTER-1 to create 
pALTR3/Alt. Both were subsequently subjected to site-directed mutagenesis using
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the pALTER system (Promega) in order to create an ATjoI site within the U3 region 
upstream of the hypervariable region. Template DNA (pPV44/Alt or pALTR3/Alt) 
was denatured by incubation in a 2 M NaOH, 2 mM EDTA solution for 5 minutes 
at room temperature followed by ethanol precipitation. The denatured template 
DNA (0.05 pmole) was incubated with 1.25 pmol mutagenic oligonucleotide 
LTRMOD+ (5'-TGCTGATGCTCGAGTAACCTTGTAT-3’) and 0.25 pmole 
ampicillin repair oligonucleotide (supplied by the manufacturer), in 20 mM Tris- 
HC1 (pH 7.5), 10 mM MgCl2, and 50 mM NaCl at 70°C for 5 minutes and allowed 
to cool slowly to room temperature. This solution was then adjusted to contain 0.5 
mM dNTPs, 1 mM ATP, 2 mM DTT, 10 units T4 DNA polymerase, and 2 units T4 
DNA ligase followed by incubation at 37°C for 90 minutes. The reaction was 
cooled and used to transform competent ES1301 mutS Eschericia Coli cells. 
Transformed ES1301 culture was incubated overnight in LB media/125 ug/ml 
ampicillin/10 ug/ml tetracycline. Plasmid DNA isolated from the overnight 
ESI301 culture was used to transform competent JM109 bacteria cells which were 
subsequently plated on LB/125 ug/ml ampicillin/10 ug/ml tetracycline. Clones 
were screened by restriction digestion and sequencing. A mutated clone, 
pA3(A7zoI)/Alt, was digested with XhoVStul and the LTR fragment was inserted 
into Xhol/Stul digested pPV44(A7zoI)/Alt to form pPVA3/Alt. Spel and Sail were 
used to remove the pPVA3/Alt envfLTR fragment which was then inserted into 
SpeUSall digested pSPEIAV44 to create pSPEIAVAd3.
Production and Propagation of Virus Strains
Approximately 2x10^ feline embryonic cells (FEA) were transfected with 
10 ug of pSPELAV44 or pSPEIAVAd3 DNA according to the calcium phosphate 
procedure discussed elsewhere. Transfected cell cultures were propagated for two
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
45
weeks in MEM/10% FCS/50 ug/ml gentamycin after transfer to 150 cm^ flasks. 
Cell culture supernatants were then stored at -70°C and used as infectious virus 
stocks in subsequent studies of viral replication kinetics and cytopathogenicity. 
Virus stocks were titered for infectivity by the end-point dilution technique. The 
end-point dilution technique involves exposing fresh cell monolayers to increasing 
dilutions of the infectious virus stock. At some point, the virus stock will be so 
diluted as to be rendered no longer infectious. After several weeks of incubation, 
the cell monolayers are assayed for production of viral antigen which indicates 
infection. The greatest dilution which still renders infection is considered to 
contain one infectious unit. With this information, the number of infectious units 
per ml for the original stock can be calculated. Five-fold dilutions of the virus 
stocks (lx l0 '3  to 3x 10"6) in a volume of 1 ml were incubated with 1x10^ FDD 
cells at 37°C for two hours. Cells were washed 3 times with PBS and then re-fed 
with MEM/5% FCS/50 ug/ml gentamycin and propagated for 18 days. Cell culture 
supernatants were subsequently assayed for viral antigen by ELISA assay. This 
procedure was run in triplicate for each virus stock allowing an average titer to be 
determined. The final titers for pSPEIAV44, pSPEIAVAd3, and AFDD were 10^, 
lO^-?, and 10^-4 infectious units per ml respectively.
ELISA assays for viral antigen
Cell culture supernatants (0.100 ml) were added to a standard 96 well 
ELISA plate containing 0.020 ml 1% Triton per well and incubated at room 
temperature for 1 hour with agitation. This treatment lysed the virus and allowed 
the viral proteins to attach to the plate. Wells were washed 3 times with 
PBS/0.05% Tween 20 (PBST)and blocked with 0.300 mis PBS/0.05% tween 
20/5% instant milk (Blotto) for 30 minutes. After washing as stated above, plates
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were dried for fifteen minutes at 37°C to irreversibly bind viral antigen and 
blocking protein to the plate. Anti-p26 rabbit polyclonal antiserum (0.100 ml at a 
1/500 dilution in blotto) was added to wells for 1 hour. Plates were subsequently 
washed and incubated 1 hour with 0.100 mis of anti-rabbit peroxidase conjugated 
antiserum (1/1000 dilution in blotto). After washing, the plates were assayed for 
peroxidase activity as stated by the manufacturer by incubation with 0.1 mg/ml 
tetramethylbenzidine dihydrochloride, and 0.006% hydrogen peroxide in 
phosphate-citrate buffer (pH 5.0) for 30 minutes at room temperature followed by 
spectrophotometric quantitation at 655 nm.
Time-course Infection of FDD Cell Cultures
Approximately 1x10^ FDD cells at 50% to 70% confluency were incubated 
with AFDD, pSPEIAV44, or pSPEIAVAd3 virus cultures at a multiplicity of 
infection of 0.1 at 37°C for 1 hour. Cells were washed three times with PBS, split 
into six 6-well tissue culture plates (35 mm) and propagated in MEM/5% FCS/50 
ug/ml gentamycin. Every 24 hours, wells were harvested for Northern and 
Southern blot analysis with the growth media saved for measurement of soluble 
reverse transcriptase activity and the viability of the cell culture was measured. 
Remaining wells were washed three times with PBS and re-fed.
Determination of Cell Culture Viability
The viability of the infected cell cultures as well as a mock-infected control 
culture was determined daily using a Cell Titer 96 AQueous Non-Radioactive Cell 
Proliferation Assay Kit (Promega) according to the manufacturers directions. This 
colorimetric procedure measures the reduction of a tetrazolium compound into a 
soluble formazan product by cellular dehydrogenase enzymes. The soluble 
formazan is subsequently released into the culture supernatant and can be
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quantitated at 490 nm. This procedure measures the overall metabolic rate of the 
cell culture which is dependent upon the number o f viable cells and their rate of 
growth. Assuming similar rates of growth, absorbance measurements obtained 
from infected cell cultures were compared to a standard curve, which plots 
absorbance versus cell number (as determined by standard trypan blue exclusion), 
for an uninfected control culture, in order to obtain the cell titer for the infected cell 
culture. Specific experimental conditions were as follows. Cell monolayers were 
washed and overlaid with 1 ml fresh growth media to which 0.200 ml of a 
MTS/PMS (3-(4,5-dimethyithiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- 
sulfophenyl)-2H-tetrazolium salt and phenazine methosulfate respectively) solution 
was added. Cultures were allowed to incubate at 37°C for 4 hours after which the 
media was quantitated at 490 nm.
Reverse Transcriptase Analysis
One of the most accurate methods to quantitate retrovirus infections is by 
measuring reverse transcriptase activity. Virus was precipitated from cell culture 
supernatants by the addition o f0.250 ml of a 40% polyethylene glycol solution and 
incubation overnight at 4°C with gentle agitation. This solution was then spun at 
12,500xg at 4°C for 15 minutes to pellet the virus. After complete removal of the 
supernatant, the virus pellet was lysed by re-suspension in 0.040 ml of solubilizing 
buffer (50 mM Tris (pH 7.8), 20% glycerol, 0.8 M NaCl, 0.5% Triton X-100, and 
0.5 mM phenylmethylsulfonylfluoride) and incubated on ice for 10 minutes. 
Solubilized virus (0.020 ml) was added to 0.180 ml of reaction buffer (52 mM Tris 
(pH 7.8), 10 mM MgCl, 5 mM DTT, 0.20 mM dATP, 0.9 ug poly(rA)-oligo(dT), 
and 52 uCi [^HjdTTP) and incubated at 37°C for 1 hour. Yeast tRNA was added to 
a final concentration of 0.1 mg/ml followed by 1 ml of ice cold 10% trichloroacetic
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acid in order to precipitate nucleic acid. The solution was kept on ice for 30 
minutes followed by filtration through a grade 25 glass microfiber filter. Filters 
were then washed three times with 1 ml of ice cold 5% TCA, 1 ml 70% ice cold 
ethanol, and 1 ml ether. Dried filters were counted in 7 mis Liquiscint liquid 
scintillation cocktail in a Beckman LSC 6000 for 1 minute. Final values reflect 
subtraction of background counts.
Isolation and Purification of Poly-adenylated RNA
Cell cultures were harvested by incubation in PBSE for 10 minutes at 37°C 
followed by three washes in PBS. Cell pellets were re-suspended in 0.400 ml 
denaturing solution (4 M guanidinium thiocyanate, 25 mM sodium citrate (pH 7), 
0.5% sodium sarcosyl, and 0.1 M 2-mercaptoethanol) and incubated on ice for 10 
minutes. Sequentially, 0.04 ml sodium acetate (pH 5.2) and 1 ml phenol (pH
4.0)/chloroform/isoamyl alcohol (25/24/1) were added and the solution incubated 
on ice for 30 minutes followed by centrifugation at 12,500xg for 15 minutes at 4°C. 
RNA was precipitated from the aqueous solution and washed in 70% ethanol. 
Poly-adenylated (Poly-A) RNA was purified from the total RNA by using a Micro- 
FastTrack mRNA isolation kit (Invitrogen) and quantitated.
Isolation and Purification of DNA
Cell cultures were harvested by incubation in PBSE for 10 minutes at 37° 
followed by three washes in PBS. Cells were re-suspended in 10 mM Tris-HCl 
(pH. 8.0), 100 mM NaCl, 0.025 mM EDTA (pH 8.0), 0.1 mg/ml Proteinase K,
0.5% SDS, and incubated at 55^C overnight. The lysate was subjected to phenol 
and phenol/chloroform extractions followed by ethanol precipitation and 
centrifugation. The pellet was re-suspended in 50 mM Tris-HCl (pH 8.0), 10 mM 
MgCl2, 50 mM NaCl, 20 ug/ml RNase A, and incubated at 37°C for one hour. The
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
49
solution was extracted with phenol/chloroform and ethanol precipitated 
sequentially in the presence of 2.5 M NH4AC to remove free nucleotides. The air 
dried DNA pellet was re-suspended in TE buffer (pH 7.6) at 50°C overnight and 
quantitated.
Northern Blot Analysis
Sequentially, 0.6 ug poly-A RNA was re-suspended in 40 mM MOPS (pH
7.0), 10 mM sodium acetate, 0.2 mM EDTA, 50% formamide, and 6% 
formaldehyde, incubated at 60°C for 15 minutes, and allowed to cool on ice. 
Glycerol, xylene cyanol, and bromophenol blue were added to final concentrations 
of 10%, 0.08%, and 0.08% respectively. Samples were applied to a 1.5% agarose 
gel that contained 6% formaldehyde. Electrophoresis was conducted in 40 mM 
MOPS (pH 7.0), 10 mM sodium acetate, 0.2 mM EDTA at 25 volts for 4.5 hours. 
Upon completion of electrophoresis, the gel was washed in lxSSC (0.15 M sodium 
chloride, 0.015 sodium citrate) and the RNA transferred to a Nytran membrane 
(Schleicher and Schuell) by the capillary method in lOxSSC overnight. The 
membrane was washed in 5xSSC for 5 minutes and then cross-linked by exposure 
to 120 mJ/cm^ of UV light in a Stratagene Stratalinker. The blot was pre­
hybridized in 50% formamide, 5xSSC, 0.1% SDS, 200 pg/ml sonicated herring 
sperm DNA, and 5xDenhardt's reagent at 42°C for 2 hours followed by 
hybridization, in fresh pre-hybridization solution plus approximately 10 ng/ml 
denatured probe (1x10^ CPM/ml), overnight at 42°C. Probe prepared using a 
Rediprime DNA labeling system (Amersham) with pSPEIAV44 as the template 
DNA and Redivue [32p]dCTP (Amersham). Washes were performed twice in 6x 
SSC, 0.5% SDS at room temperature for 15 minutes, twice in lxSSC, 0.5% SDS at 
37°C for 15 minutes, once in O.lxSSC, 0.1% SDS at 65°C for 30 minutes, and once
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in O.lxSSC at room temperature for 15 minutes. The damp membrane was inserted 
between two plastic transparency sheets and exposed to X-OMAT AR (Kodak) X- 
ray film for 24 to 48 hours.
Southern Blot Analysis
Cellular DNA (5.0 ug) was digested to completion with Stul, which cuts the 
EIAV genome in the LTR U5 region exclusively. Glycerol, xylene cyanol, and 
bromophenol blue were added to final concentrations of 10%, 0.08%, and 0.08% 
respectively and the sample was subjected to electrophoresis in a 0.8% agarose gel 
in TAE for 16 hours at 20 volts. Upon completion of electrophoresis, the gel was 
soaked once in 0.25 M HC1 for 10 minutes, twice in 1.0 M NaCl, 0.5 M NaOH for 
15 minutes, and twice in 1.5 M NaCl, 0.5 M Tris (pH 7.4). The fractionated DNA 
was then transferred to a Nytran membrane (Schleicher and Schuell) by the 
capillary method in lOxSSC overnight. The membrane was washed in 5xSSC for 5 
minutes and then cross-linked by exposure to 120 mJ/cm^ of UV light in a 
Stratagene Stratalinker. The blot was pre-hybridized in 50% formamide, 6xSSC, 
0.5% SDS, 200 ug/ml sonicated herring sperm DNA, and 5xDenhardt's reagent at 
42°C for 2 hours followed by hybridization, in fresh pre-hybridization solution plus 
approximately 10 ng/ml denatured probe (1x10? CPM/ml), overnight at 42°C. 
Probe prepared using a Rediprime DNA labeling system (Amersham) with 
pSPEIAV44 as the template DNA and Redivue [32p]dCTP (Amersham). Washes 
were performed twice in 7xSSC, 0.5% SDS at room temperature for 15 minutes, 
twice in lxSSC, 0.5% SDS at 37°C for 15 minutes, once in O.lxSSC, 0.5% SDS at 
65°C for 30 minutes, and once in O.lxSSC at room temperature for 15 minutes.
The damp membrane was inserted between two plastic transparency sheets and 
exposed to X-OMAT AR (Kodak) X-ray film for 72 hours.
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Immunofluorescent Slide Staining
Cell monolayers were washed once in PBS and harvested in 1 ml PBSE. 
Cell suspensions were streaked onto gelatin coated slides and allowed to air dry. 
Cell smears were fixed by incubation in acetone/formaldehyde fixing solution for 
30 seconds at room temperature and air dried. Fixed slides were incubated in 
blocking solution (PBS with 5% BSA) for 1 hour followed by incubation in PBS 
plus rabbit polyclonal antiserum against EIAV protein gp90 (1/50 dilution) for 2 
hours. Smears were washed for 10 minutes in PBS/tween 20 (0.5%) 3 times and re- 
blocked in PBS/BSA for 1 hour followed by incubation with anti-rabbit fluorescein 
conjugate diluted 1/100 in PBS for 2 hours. All of these steps were performed at 4° 
C. Following final washing (3 times in PBS/tween 20), ceils were photographed 
using a fluorescent light source at 400x magnification.
Competitive PCR
Reactions were performed primarily by Pramod Vijayagopal of Dr. Ding 
Shih's laboratory using horse tissue genomic DNA kindly provided by Dr. Susan 
Payne. Genomic DNA was isolated from liver, lung, kidney, and lymph node 
tissues of a horse euthanized during an acute disease episode after being 
experimentally infected with the Wyoming strain of EIAV. Samples were isolated 
and purified by Dr. Payne using Qiagen DNA purification columns according to the 
manufacturers directions and supplied to this investigator in a lyophilized form.
The control plasmids, pDl/GL2 and pD3/GL2, were constructed from LTR variants 
p3.2-l and p3.2-3 which were removed from pSVO as Hindlll fragments and cloned 
into the tfmdlll site of pGL2-Enhancer. Deletion of 58 bp from the U5 regions of 
these LTRs was accomplished using the primer directed method outlined elsewhere 
and the primer pair <-LTRP21 (5-AGAAGGGACTCAGACCGCA-3') and —»
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LTRP22 (5'-GTTTGTCTGTTCGAGATCCTA-3') which delete LTR sequences 
between nucleotides 32 and 90. This deletion allows control plasmid amplification 
products to be separated from tissue DNA products electrophoretically. The 
oligonucleotide primer -»P-3 (5’-TAAAATGTAGTTCCTCAATATAGTTCCG-3') 
is identical to a unique region (nucleotides -111 to -84) of variant LTR 3.2-3 and 
will only amplify similar LTR variants. Primer -»P-1 (5- 
ATTTGTGACGCGAGTTCCCCATTGG-31) is identical to a unique region 
(nucleotides -84 to -58)of variant LTR 3.2-1 and will only amplify similar variants. 
The primer <-P-C (5'-GTAGGATCTCGAACAGACAAAC-3') is complementary 
to a region at the end of the LTR (nucleotides 112 to 91) and will recognize both 
types of LTR variants. Reactions were performed in 20 mM Tris-HCl, 10 mM 
KC1,10 mM (NH4)2S04, 0.1% Triton X-100, 6 mM MgS04, 200 uM dNTPs, 200 
uM [a-35s]dATP, 1 uM primers (-»P-1 and <—P-C or —>P-3 and «-P-C), 150 ng 
infected tissue DNA (liver, lymph node, lung, or kidney), 300 to 0.003 pg control 
plasmid DNA (pDl/GL2 or pD3/GL2), and 2 units Taq polymerase at 94°C (60 
seconds) and 60°C (30 seconds) for 35 cycles. Reactions were resolved on 8% 
non-denaturing polyacrylamide gels in lxTBE at 50 volts for 5 hours. Gels were 
fixed in 7% acetic acid for 20 minutes followed by vacuum drying and exposure to 
X-omat AR film for 24 hours at room temperature.
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CHAPTER 3 
RESULTS AND DISCUSSION 
Comparative Analysis of Variant LTR Sequences
The prototype LTR, Prtt, was obtained from a proviral DNA clone of EIAV, 
XI2. (Rasty et a l, 1990). It contains a number of possible transcription factor 
binding sites including a PU.l an AP-1, and two PEA2 motifs. These sites have 
been identified using a variety of established cell lines such as human monocytic 
(U937), cervical carcinoma (Hela), canine osteosarcoma (D17), and equine 
fibroblasts (equine 6288), as well as primary horse macrophage cultures (Carvalho 
and Derse, 1993a; Carvalho and Derse, 1993b; Carvalho et al., 1993; Maury,
1994). Although the EIAV LTR may form unique transcription factor complexes 
within each different cell type, these motifs influence promoter activity in some 
manner in almost every cell culture in which the LTR has been studied. Therefore, 
it is likely that some of these same motifs influence the promoter activity of the 
LTR within FDD, Cf2Th, and FEA cells as well.
Sequence variations within the EIAV LTR that result in duplication or 
modification of these sites is well documented. These variations can influence the 
promoter strength of the LTR in a cell-line dependent manner (Carpenter et al., 
1991; Carvalho et al, 1993) and it has been suggested that they may play a role in 
influencing cellular tropism of the virus in vivo. In addition, the LTR directly 
influences the quantity of viral mRNA, the levels of which, in turn, influence the 
replication kinetics or replication capacity of the virus. While a higher replication 
rate may result in a more virulent sub-type of virus, increasing the severity of 
disease episodes, a lower relative rate of replication, resulting in attenuation, may 
cause the virus to establish less severe, persistent infections. Due to the lack of a
53
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pathogenic molecular clone, this study relied primarily on in vitro experiments, 
examining the effects of LTR variation on promoter strength, replication, and 
cytopathogenicity, in order to implicate LTR sequence variation in virus pathology.
The first step of this investigation involved the sequence analysis of 
multiple LTR variants from a variety of sources. ALTR3 and ALTR4 were 
amplified from the cellular DNA of FDD cell cultures infected with FDD-adapted 
virus (AFDD), a virus stock that demonstrates accelerated cytopathogenic effects in 
FDD cell cultures, using the polymerase chain reaction. Six of the positive clones 
identified were sequenced and their homology analyzed by the software program 
Pileup (Genetics Computer Group). This program generates an alignment of 
multiple DNA sequences representing their maximum homology. The six AFDD 
LTR sequences analyzed were highly homologous with a maximum variability of 
only 1.6 percent. AFDD LTR clone 3, ALTR3, and clone 4, ALTR4, were chosen 
for subsequent functional studies as they represent the majority of LTR sequence 
variants within the AFDD strain. These sequences were aligned and compared with 
Prtt (Fig. 4). Alignments were based on maximum sequence homology and 
numbered relative to the ALTR3 sequence. The hypervariable region of ALTR3 
differs from the corresponding Prtt region in that it contains a 20 bp sequence 
insertion, upstream of the putative transcription start site of ALTR3 beginning at 
position -58, as well as an additional adenine residue at position -51. ALTR3 also 
contains three transitions relative to Prtt; a thymine to cytosine at -135, an adenine 
to guanine at -164, and a thymine to cytosine at position -3. These mutations may 
have a significant effect on transcription factor binding sites or regulatory elements 
previously identified in the prototype LTR. The large sequence insertion causes 
imperfect duplications of the putative PU.l and AP-1 binding sites and the
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Figure 4. Sequence comparison of variant LTR isolates. Alignment of LTR 
variants isolated from FDD-adapted virus, (ALTR3 and ALTR4), molecular clone 
X12 (Prtt), molecular clone pSPELAV44 (PV44), and three sequential isolates from 
an infected pony (p3.2-l, p3.2-3, and p3.2-5). Alignments were based on 
maximum sequence homology and numbered relative to the transcription start site 
of ALTR3. Transcription factor recognition sites, TATA box, and TAR element, 
are also shown.
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-210
ALTR3: TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA GTAAAAGGAA
ALTR4: A
3.2-1: A
Prtt: A
PV44: A
3.2-3: A
3.2-5: A
-160
ALTR3: AGTTGCTGAT GCTCTCATAA CCTTGCATAA CCCAAAGGAC TAGCTCATGT
ALTR4: T
32-1: T
Prtt: T
PV44: T
3.2-3: T
3.2-5: T
-HO PEA2 _________________ PEA2_________________
ALTR3: TGCTAGGCAA CTAAACCGCA ATAA-----------------------------------------------CCGCAT
ALTR4:
3.2-1:
Prtt:
PU.l PU.l
PV44: A ATGCAGTTTC TCAATATAGT T
3.2-3: AATGTAGTTTC TCAATATAGT T
3.2-5: ACTGAGTTCC TCAATATAGT T
-80 AP-1 PU.l AP-1 PU.l
ALTR3: TTGTGACGCG AGTTCCACAT TTGTGACGCA TTTAACTTCC TGTTTTTACA
ALTR4: —
3.2-1: C G — G
P r t t : ------------------------------------------------------------- G
PV44: -------------------------------------------- -  G
3.2-3 : ------------------------------------------------------------- G
3.2-5:------------------------TA---------------------------- -----------------  G
-30 +J___________ TAR__________
ALTR3: GTATATAAGT GCTTGTATTC TGACAATCGG GCACTCAGAT TCTGCGGTCT
ALTR4:
3.2-1: T
Prtt: T
PV44: T
3.2-3: T
3.2-5: T
21______
ALTR3: GAGTCCCTTC TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT
71
ALTR3: CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC A
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additional adenine at position -51 brings the original AP-1 site closer to a 
consensus recognition sequence (TGASTMA) (Carvalho and Derse, 1993a; 
Carvalho and Derse, 1993b; Diamond et al., 1990; Maury, 1994). ALTR4 is very 
similar to ALTR3 except it retains an adenine residue at position -164, a thymine at 
position -135, and is missing three thymine residues at positions -79 to -81. Based 
on sequence analysis, the AFDD LTR contains a number of mutations that could 
create additional transcription factor binding sites or modify pre-existing ones.
The cognate LTR, PV44, of pSPEIAV44, an infectious molecular clone of 
EIAV produced from the virulent cell culture stock PV (Payne et al., 1994), was 
also compared to the Prtt, ALTR3, and ALTR4 sequences. It contains an insertion 
of 21 bp, relative to Prtt, within the hypervariable region but this insertion causes 
the formation of a possible PU.l site without the creation of a new AP-1 site as 
seen in AFDD LTR sequences. The insertion also interrupts one of the putative 
PEA2 sites (GACCGCA) (Carvalho and Derse, 1993a).
Additional variants, 3.2-1, 3.2-3, and 3.2-5 were isolated during sequential 
disease episodes experienced by an experimentally infected pony (Payne et al., 
1987). Although derived from the same host, variant 3.2-1 is more homologous to 
ALTR3 and ALTR4 while variants 3.2-3 and 3.2-4 are more homologous to PV44. 
Isolate 3.2-1 contains a 20 bp insertion/duplication almost identical to that of 
ALTR3 and ALTR4 with the exception of adenine to cytosine and thymine to 
guanine base pair transitions at positions -74 and -59 respectively. With the 
exception of the insertion, 3.2-1 is identical to Prtt. Therefore, like ALTR3 and 
ALTR4, it contains imperfect duplications of the putative AP-1 and PU.l binding 
sites but, like Prtt, its original AP-1 site is less homologous to the consensus 
recognition sequence. Variant 3.2-3 contains an insertion almost identical to that of
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PV44 with the exceptions of an additional adenine residue at the beginning and a 
cytosine to thymine transition 4 bp downstream of the additional adenine. Neither 
of these mutations would create or interfere with any of the recognition motifs 
identified in the discussion of PV44. Other than the insertion, 3.2-3 is identical to 
Prtt. Variant 3.2-5 is a very unique variant in that it contains two significant 
insertions. It contains a 21 bp insertion between positions -86 and -87 which is 
very similar to that of PV44 with one significant exception. A thymine to cytosine 
transition 9 nucleotides into the insertion creates a second possible PU. 1 
recognition motif. The transition restores the TTCC core binding motif found in 
the original PU.l site. In addition, 3.2-5 contains 5 bp identical to nucleotides -78 
to -74 of ALTR3 followed by additional thymine and adenine nucleotides. The 
remainder of variant 3.2-5 is identical to Prtt. Therefore, variant 3.2-5 may contain 
up to three PU.l and two AP-1 binding sites in close proximity to the TATA box.
In order to facilitate the cloning of ALTR3 into the proviral clone 
pSPEIAV44, an ATroI site was produced by site-directed mutagenesis in a region 
believed to be devoid of any transcription factor binding motifs. A3(Xhol) was 
included in subsequent transient gene expression studies to verify that this mutation 
had no effect on the promoter strength of the LTR.
As can be seen by these comparisons, the EIAV LTR shows considerable 
heterogeneity even when isolated from the same host. The greatest region of 
disparity is centered approximately 70 nucleotides upstream of the TATA box. It is 
interesting to note that LTR variants, despite the source, can be separated into two 
broad classes based upon their sequence homology and transcription factor motifs. 
Those that contain two PEA2, AP-1, and PU.l sites such as ALTR3, ALTR4, and
3.2-1 and those that contain only one PEA2 and AP-l but three possible PU. 1
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binding sites such as 3.2-3,3.2-5, and PV44. Of course, this is a very loose 
classification as small mutations can destroy possible binding sites such as the third 
PU.l site or create additional AP-1 sites as seen in variants PV44,3.2-3, and 3.2-5 
respectively. The Prtt LTR, which is the shortest functional LTR isolated to date, 
would fall into neither category.
Relative Promoter Strength of Variant LTR Sequences
To assess the impact of sequence variation within the AFDD LTR on its 
promoter strength, transient gene expression assays were performed using FDD, 
Cf2Th, and FEA cell cultures. Variant LTR sequences ALTR3, ALTR4,
A3(Xhol), 3.2-1, Prtt, PV44, 3.2-3 and 3.2-5 were placed upstream of the 
chloramphenicol acetyl transferase, CAT, gene of pSVO/CAT (Gorman et al., 1982) 
and transfected into cells by the calcium phosphate precipitation technique. Values 
represent the mean of at least six trials, normalized with P-galactosidase activity, 
with standard error and statistical significance as indicated (Table 3).
In FDD cell cultures, variant 3.2-5 was the least active promoter under basal 
conditions. Despite their slightly higher activity, Prtt, PV44, and 3.2-3 did not 
behave significantly different from 3.2-5 while ALTR3, ALTR4, A3(Xhol), and
3.2-1 were 5 to 9 times as active. The high activity of ALTR3, ALTR4, A3(Xhol), 
and 3.2-1 relative to the remainder of the variants indicates that the duplicated AP-1 
motif, common only to these four variants, or an unidentified overlapping motif is 
responsible for the increase in promoter strength. Although these four variants also 
share a duplicated PU.l site, it seems unlikely that this motif is responsible for their 
increased promoter strength as PV44, 3.2-3 and 3.2-5 also contain duplicated PU.l 
motifs. Variant 3.2-5 contains an additional possible AP-1 site, but it is less 
homologous to the consensus recognition sequence and appears to be inactive. The
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lack of any discernible difference in activity between ALTR3, ALTR4, and 
A3(Xhol) indicates that the small sequence differences between these variants are 
irrelevant. Although highly homologous in sequence, ALTR4 was almost twice as 
active as 3.2-1. Therefore, LTR variants which contain similar sequence insertions 
tend to behave approximately the same in vivo but smaller mutations can create 
significant differences. In the case of ALTR4 and 3.2-1, the additional adenine 
residue and guanine to thymine transition, nucleotide positions -51 and -50 
respectively, in ALTR4 create a more optimal AP-1 recognition sequence which 
may be responsible for increasing its promoter strength relative to 3.2-1. It is also 
possible that the thymine to cytosine transition at nucleotide -3 may influence 
activity in an unidentified manner. When co-transfected with the EIAV Tat 
expression plasmid pSV720 (Schiltz et al., 1992), the constructs showed different 
stimulation of expression over basal levels. Prtt, PV44,3.2-3 and 3.2-5 showed 
considerable stimulation, 17 to 25 fold, but ALTR3, ALTR4, A3(A7ioI), and 3.2-1 
showed only a 5 to 10 fold stimulation making them approximately twice as active 
as Prtt, PV44, 3.2-3 and 3.2-5 under transactivated conditions. In general, the 
magnitude of transactivation was inversely proportional to the basal activity. This 
effect causes the large differences in activity between LTR sequences under basal 
conditions to become less distinctive when under transactivated conditions. A 
similar effect has also been observed in studies of transactivation with the HIV-1 
LTR (Antoni et al., 1994). Although less distinctive under transactivated 
conditions, there were still significant differences in levels of activity between 
different LTR variants. For example, 3.2-1 remains more than twice as active as 
Prtt.
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Table 3. Variant LTR activity in FDD cell cultures.
CPM/uU B-Gal.
Construct Basal
pALTR3/CAT 1744 ± 428s
pALTR4/CAT 1921 ±240s
pA3(XhoI)/CAT 1658 ± 3 l8s
p3.2-l/CAT 1105 ±264s
pPrtt/CAT 242 ±31
pPV44/CAT 343 ± 78n
p3.2-3/CAT 351 ±76n
p3.2-5/CAT 215 ± 58n
Transactivated Fold Increase
8178±457s 5
10050±817s 5
8995 ± 673s 5
11293 ±792s 10
5406 ±227 22
5800 ± 579n 17
6664 ± 559n 19
5448 ± 580n 25
In FEA cell cultures, only the promoter activity of LTR variants 3.2-1, Prtt,
3.2-3, and 3.2-5 were measured (Table 4). Variants 3.2-1 and 3.2-5 were the most 
active promoters in this cell type producing twice as much CAT activity as Prtt. 
Although the average activity of 3.2-3 was higher than that of Prtt, it did not behave 
significantly different. The only sequence motif common to these three variants 
that is not found in Prtt is the duplicated PU. 1 motif. Based on this comparison, it 
seems likely that the PU.l motif, or an overlapping one, is being recognized by a 
transcription factor expressed in FEA cells. The second PU.l site duplication 
found in 3.2-5 may be inactive either due to sequence differences or due to its 
location further upstream from the TATA box. One of the most striking differences 
between the results obtained in FEA cells and results obtained in FDD cells is the 
magnitude of transactivation. Co-transfection with pSV720 resulted in as much as 
a 90 fold increase in activity in FEA cells as apposed to the maximum increase of
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only 25 fold seen in FDD. Without the quantitation of cellular Tat levels, it is 
difficult to discern whether this effect represents a difference in the mechanism of 
transactivation or whether it is an experimental artifact caused by the expression 
levels of EIAV Tat being different between the two cell lines. Similar to what was 
seen in FDD cells, the magnitude of transactivation was inversely proportional to 
the level of basal activity.
Table 4. Variant LTR activity in FEA cell cultures.
CPM/uU B-eal
Construct Basal Transactivated Fold Increase
p3.2-1/CAT 270 ± 35s I1489±1919n 55
pPrtt/CAT 127 ±29 14789 ±2427 90
p3.2-3/CAT 223 ± 38n 15012 ±3459n 67
p3.2-5/CAT 304 ±3 Is 14390 ±2564n 47
In Cf2Th cells, LTR variants 3.2-1 and Prtt exhibited the strongest promoter 
activities showing more than twice the activity of 3.2-3 which was the weakest 
promoter in this cell type (Table 5). Variants ALTR3, ALTR4, A3(A7ioI), and 
PV44 were not used in this study. Based on sequence homology, the most likely 
motif responsible for the increased activity produced by 3.2-1 and Prtt is a PEA2 
recognition site. There are two such possible sites in both Prtt and 3.2-1 while 3.2- 
3 and 3.2-5 have only one. The second site in the latter variants being interrupted 
by sequence insertions. Although it demonstrates lower activity, p3.2-5 does not 
differ significantly from Prtt. Variant 3.2-5 might be forming a transcription factor 
complex different from both Prtt and 3.2-3 but what this difference might be is
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unknown. Although the magnitude of transactivation in Cf2Th cells was not as 
pronounced as in FEA cells, it still tended to be larger than the magnitude of 
transactivation in FDD cells. The maximum increase in activity in Cf2Th cells was 
38 fold whereas it was only 25 fold in FDD cells. As discussed previously, without 
a quantitation of cellular Tat levels it is impossible to conclude whether this result 
represents a difference in the mechanism of transactivation or is merely the result of 
more Tat being expressed in Cf2Th cells relative to FDD cells.
Table 5. Variant LTR activity in Cf2Th cell cultures.
CPM/uU B-eal
Construct Basal Transactivated Fold Increase
p3.2-l/CAT 284 ± 39n 6366±630n 22
pPrtt/CAT 236 ±53 4985 ±572 21
p3.2-3/CAT 112 ± 13s 4263±509n 38
p3.2-5/CAT 160±20n 4738±516n 30
In combination, these results indicate that LTR variants behave differently 
in a cell line dependent manner. Thus LTR variation could strongly influence the 
adaptation of a virus quasi-species to a particular cell line in vitro and, by analogy, 
influence cellular or tissue tropism in vivo. Based on the results obtained from 
FDD cell cultures, which showed dramatic differences in activity levels under basal 
conditions, it can also be speculated that LTR variation could influence the 
virulence of a virus sub-type by increasing or decreasing its replication rate. The 
identities of the transcription factors that actually interact with the LTR variants in 
these cell types remain to be determined conclusively but some likely possibilities
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have been discussed based upon previous studies, sequence analysis, and basal 
promoter strengths. Although the differences in promoter strength between variants 
became less pronounced under transactivated conditions, they often remained 
significant. The magnitude of transactivation was also dependent upon cell type 
but it is difficult to conclude whether this represented a difference in mechanism or 
was an experimental artifact.
Deletion Analysis of the LTR
Reporter constructs containing deletions within the U3 region of Prtt, 
pD(Alul/Hincll)/CAT, PD(///«dIII///mcII)/CAT, and pD(//mdIIIA4M)/CAT were 
created using existing restriction enzyme sites in order to localize regions 
predominately responsible for transcriptional activity. Prtt is the most highly 
characterized EIAV LTR. Previous deletion studies, performed in a variety of cell 
lines, with this variant indicated that virtually all the active enhancer elements were 
located proximal to the hypervariable region (Carvalho et al., 1993; Carvalho et al., 
1993; Dom et al., 1988; Sherman et al., 1989). In order to confirm these 
observations, these three Prtt deletion mutants were transfected via the calcium 
phosphate precipitation technique into FDD, FEA, and Cf2Th cells. Values 
represent an average of three trials, normalized with P-galactosidase activity, with a 
standard error and statistical significance as indicated. The deletion mutants are 
missing either the hypervariable region and flanking sequences, 
pD(Alul/Hincll)ICAT (nucleotides -48 to -117), the remainder of the U3 region, 
pD(Hindlll/Alul)/CAT (nucleotides -118 to -210), or both regions, 
pD(//mdIII///mcII)/CAT (nucleotides -48 to -210) (Fig. 5).
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-210 NF-icB NF-kB
pALTR3/CAT: TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA
pPrtt/CAT: 
pD(^/«I///mcII)/CAT:
pD(///ndIII//l/aI)/CAT: ----------------------------------------------------------------------------------------
pD(//mdIII///mc[I)/CAT:----------------------------------------------------------------------------------------
-120
ALTR3/CAT: GTAAAAGGAA AGTTGCTGAT GCTCTCATAA CCTTGCATAA
pPrtt/CAT: A T
pD(AluUHincUyCAT. A T
pD(//i/idIIIM M )/CAT:----------------------------------------------------------------------------------------
pD(HmdllVHincU)/CAT:--------------------------------------------------------------------------------------------------------------
-130 ' PEA2
ALTR3/CAT: CCCAAAGGAC TAGCTCATGT TGCTAGGCAA CTAAACCGCA
pPrtt/CAT:
pD(AluUHincll)/CAT: --------------------------------------------------------------------------
pD(///>jdIII//l/«I)/CAT: -----------------------------
pD(tfwdIII////>7ClI)/CAT:----------------------------------------------------------------------------------------------------------
-90 PEA2 AP-1 PU.l AP-1
ALTR3/CAT: ATAACCGCAT TTGTGACGCG AGTTCCACAT TTGTGACGCA
pPrtt/CAT:---------------------------------------------- ---------------------------------------------
pD(AluVHincliyCAT: ----------------------------------------------------------------------------------------------------------------
p D ( H i n d l l U A l u l ) / C A 7 : --------------------------------------------------------
pD(HindlWHincll)/CAT:----------------------------------------------------------------------------------------------------------------
-50 PU.l
ALTR3/CAT: TTTAACTTCC GTTTTTACA GTATATAAGT GCTTGTATTC
pPrtt/CAT: G
pD(AluVHincll)/CAT: —
pD(////idIIIA4/Ml)/CAT: G
pD(///«dIII////«cII)/C AT: —
-JO +J______________JAR_____________
ALTR3/CAT: TGACAATCGG GCACTCAGAT TCTGCGGTCT GAGTCCCTTC
+31
ALTR3/CAT: TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT
+71
ALTR3/CAT: CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC
Figure 5. Alignment of Prtt LTR deletion mutants. The LTR regions of reporter 
constructs ALTR3/CAT and Prtt/CAT are shown aligned with deletion constructs derived 
from Prtt/CAT. Deletion constructs are missing the hypervariable region and flanking 
sequences (pD^/wI/Z/mcIiyCAT), U3 sequences upstream of the hypervariable region 
(pD(//mdIIIM/uI)/CAT), and removal of both regions (pD(MndIIU//mcII)/CAT). 
Putative c/s-elements are also identified.
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In FDD cell cultures, deletion of sequences encompassing the hypervariable 
region, as indicated by pD(AluVHindi. )/C AT, resulted in greater than a 10 fold 
decrease in basal activity when compared to Prtt (Table 6). In addition, deletion of 
the these sequences seemed to affect transactivation by EIAV Tat. When co­
transfected with pSV720, this mutant showed less than a 4 fold stimulation making 
it 78 fold less active than Prtt under transactivated conditions. Deletion of 
upstream U3 sequences, as shown by pD(//mdIIIA4/wI)/CAT, exhibited a less 
pronounced but significant, 2 to 3 fold, drop in basal activity while showing a 42 
fold stimulation upon transactivation. Strangely, deletion of almost the entire U3 
region, as shown by pD(///«dIII////«cII)/CAT, also resulted in a 10 fold decrease in 
activity under basal conditions but the magnitude of transactivation was restored to 
25 fold.
Table 6. Prtt deletion mutant activity in FDD cell cultures.
CPM/uU B-eal
Construct Basal Transactivated
pPrtt/CAT 250 ± 17 6583 ±616
pD(Alul/Hincll)/CAT 23 ± 5s 84 ± 15s
pD(HindlIUAluI)/CAT 99 ± 10s 4169±494s
pD(HindIIVHinclI)/CAT 25 ± 2s 629±130s
Fold Increase 
26 
4 
42 
25
The results obtained with pD(Alul/HincU)/CAT and pD(///«dIIIA4/«I)/CAT 
indicate that in FDD cells, enhancer elements close to the hypervariable region 
have the greatest effect on transcription rate, but enhancer element(s) further 
upstream also exert a significant influence. The dramatic decrease in the magnitude
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of transactivation caused by deletion of the hypervariable region might have been 
caused by the removal of a recognition element(s) recognized by a cellular factor(s) 
that either directly interacts with Tat or is indirectly required for Tat function.
In FEA cells, none of the deletion construct activities differed significantly 
from Prtt under basal conditions. The deletion mutant pD(yfM///mcII)/CAT 
exhibited only 35% less activity than Prtt (Table 7). Thus the hypervariable region 
may exert far less influence on basal expression in FEA as opposed to FDD cells. 
This deletion construct still contains an intact PU.l motif directly upstream of the 
TATA box, however, and transient gene expression assays with full-length LTR 
variants indicated that PU. 1 motifs were being recognized by a factor in FEA cells. 
Therefore this PU.l motif may be responsible for maintaining the relatively high 
basal transcription rate. Similar to what was observed in FDD cells, deletion of the 
hypervariable region decreased the magnitude of transactivation from 54 fold, as 
seen with pPrtt/CAT, to only 6 fold, as shown by pD(Alul/Hincll)/CAT. The 
simplest explanation for this result would be that EIAV Tat indirectly requires a 
DNA c/s-element in order to function efficiently but results obtained with 
pD(///«dIII///wcII)/CAT contradict this theory. Removal of almost the entire U3 
region, pD(/fmdIII///mcII)/CAT, dropped the basal activity only 29% compared to 
Prtt and, similar to what was observed in FDD cells, this deletion did not seem to 
affect the magnitude of transactivation, as a 26 fold induction in activity was seen 
under transactivated conditions. Deletion of upstream U3 sequences, 
pD(//mdIII/4/wI)/CAT, actually increased activity under basal conditions by 38%. 
A previous study performed using FEA cell cultures also indicated a possible 
negative regulatory element in this region (Dorn and Derse, 1988). This deletion 
did not have any discernible effect on the magnitude of transactivation.
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Table 7. Prtt deletion mutant activity in FEA cell cultures.
CPM/uU B-gal
Construct Basal Transactivated Fold Increase
pPrtt/CAT 173 ±30 9410 ±820 54
pD(Alul/HinclT)/CAT ll2 ± 2 8 n  631 ± 233s 6
pD(tfmdIIIM/uI)/CAT 239±50n 7951 ± 1408n 33
pD(/7mdIII////ncII)/CAT 123 ±3 In 3153 ± 929s 26
Cf2Th cells transfected with pD(Alul/Hincll)/CAT yielded results similar to 
those obtained in FEA cells (Table 8). None of the deletion constructs exhibited 
behavior significantly different than that of Prtt. There was a 35% drop in activity 
under basal conditions and a virtual elimination of induction by transactivation. 
Deletion of upstream U3 sequences, pD(/fmdIIIM/«I)/CAT, also lowered basal 
activity by 35% but did not affect transactivation as activity was induced 16 fold in 
the presence of Tat. Deletion of both regions, pD(MrtdIII////«cII)/CAT, resulted in 
only a 29% drop in basal activity, but unlike the behavior observed in FDD or FEA 
cell cultures, the deletion also resulted in a loss of response to transactivation.
Table 8. Prtt deletion mutant activity in Cf2Th cell cultures
CPM/uU B-gal
Construct Basal Transactivated Fold Increase
pPrtt/CAT 181 ±24 3453 ±570 19
pD(Alul/Hincll)/CAT 115±20n 152±9s 1
pD(//mdIII//4M)/CAT 118±23n 1937 ± 256s 16
pD(//mdIII///mcII)/CAT 129±56n 432 ± 54s 3
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The identity of the actual cw-element(s) involved in the behavior of the 
three deletion mutants can only be speculated upon using previously published 
data. The results obtained in these studies indicate that the transcription factor 
complexes formed with the EIAV LTR are quite different between cell lines. 
Deletion of U3 sequences encompassing the hypervariable region and flanking 
sequences, illustrated by pD(AluUHincll)/CAT, had a profound impact on promoter 
activity in FDD but not FEA or Cf2Th cells. Even deletion of virtually the entire 
U3 region, as shown by pD(Hindlll/HmclT)/CAT, had no significant effect on basal 
activity in FEA or Cf2Th cells. There are three feasible explanations for these 
results. The intact PU.l motif in proximity to the TATA box may be sufficient to 
maintain transcription at a relatively high rate. Studies with full-length LTR 
variants, however, indicated that the PU.l motifs were only actively recognized in 
FEA cells. It is also possible that the presence of the TATA box itself is sufficient 
to maintain basal transcription in these cell lines and that upstream enhancer 
elements influence transcription in only a minor way. The last possible explanation 
is that unidentified enhancer elements in the R and U5 regions of the LTR are being 
recognized by factors in these cell lines. Another interesting observation made 
during these studies was that transactivation was abrogated in FDD, FEA, and 
Cf2Th cell lines upon deletion of the hypervariable region and flanking sequences, 
but upon deletion of the entire U3 region, induction of transcription by Tat was 
restored in FDD and FEA but not in Cf2Th cells. Using horse PBMC cultures, 
Maury (1994) showed that the PU.l sites in the EIAV LTR were essential for 
transactivation but had little affect on basal activity. She also demonstrated that 
sequences 5' to the PU.l core motif were required for efficient recognition of this
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motif by cellular factors. Therefore, it is possible that FEA and FDD cells simply 
require a recognition element in proximity to the TATA box for transactivation. As 
already discussed, an intact PU.l element is present in all three deletion mutants, 
however, it is only two base pairs downstream of the Hincll site used in the 
construction of the deletion mutants. Deletion of sequences between the Alul and 
Hincll sites and their subsequent blunt-end ligation, as described for the creation of 
pD(^/«I///iwcII)/CAT, may have removed nucleotides 5' to the PU.l site essential 
for its recognition. The ligation of the Hincll site to the synthetic Hindlll linker 
sequence, as described in the creation of pD(7//rtdIII////ncII)/CAT, may restore the 
essential nucleotides. The study by Maury (1994) also showed that Cf2Th cells did 
not require the PU. 1 motifs for basal activity nor transactivation. Therefore, while 
the PU. 1 motif may be sufficient to restore Tat responsiveness in FDD and FEA 
cells, Cf2Th cells seem to require a different element altogether which would 
explain why induction by EIAV Tat was not observed in C£2Th cells transfected 
with pD(///ndIII//fmcII)/CAT as well as \iD(AlulIHincll)ICKY. To date, no studies 
have shown that EIAV Tat recognizes any DNA cw-elements. Therefore, any 
interaction an element would have with EIAV Tat must be an indirect one via the 
cellular factor which recognizes it.
Analysis of ALTR3 Deletion Mutants
Oligonucleotide directed deletion mutagenesis was performed on ALTR3 to 
further localize LTR c/s-elements active in FDD cell cultures and to study the 
impact of mutations within the hypervariable region on promoter strength.
Deletion sizes varied depending on their location within the LTR. Large deletions 
were created in regions where no transcription factor binding sites had previously
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pALTR3/Luc: 
pD(-210/-185)/Luc: 
pD(-181/-135)/Luc:
-210 NF-kB NF-kB
TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA
ALTR3/Luc: 
pD(-l 81/-135)/Luc: 
pD(-137/-l I8)/Luc:
-170
GTAAAAGGAA AGTTGCTGAT GCTCTCATAA CCTTGCATAA
ALTR3/Luc: 
pD(-137/-l 18)/Luc: 
pD(-l 17/-lOI)/Luc: 
pD(-94/-87)/Luc:
-130 PEA2
CCCAAAGGAC TAGCTCATGT TGCTAGGCAA CTAAACCGCA
ALTR3/Luc: 
pD(-94/-87)/Luc 
pD(-85/-80)/Luc 
pD(-77/-61)/Luc 
pD(-57/-43)/Luc
-90 PEA2 AP-1 PU.l AP-1
ATAACCGCAT TTGTGACGCG AGTTCCACAT TTGTGACGCA
ALTR3/Luc:
pD(-57/-43)/Luc:
pD(-46/-31)/Luc:
-50 PU.l
TTTAACTTCC GTTTTTACA GTATATAAGT GCTTGTATTC
ALTR3/Luc:
pD(l/26)/Luc:
-10 +]_____________ TAR_____________
TGACAATCGG GCACTCAGAT TCTGCGGTCT GAGTCCCTTC
ALTR3/Luc:
pD(32/90)/Luc:
+31
TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT
ALTR3/Luc:
pD(32/90)/Luc:
+71
CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC
Figure 6. Alignment of ALTR3 deletion mutants. Deletion mutants were created 
from the reporter construct ALTR3/Luc using a primer directed method as outline 
in Materials and Methods. The LTR regions of the resulting deletion constructs are 
shown aligned with the LTR region of pALTR3/Luc with deleted sequences as 
indicated. Putative c/s-elements for the EIAV LTR are also shown.
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been identified while smaller deletions, of sequences in or near the hypervariable 
region, were produced to remove putative motifs identified in previous studies or 
by sequence analysis (Fig. 6). These deletion mutants were placed upstream of the 
luc gene of the pGL2-Enhancer vector and the promoter strengths measured under 
both basal and transactivating conditions. The pGL2-Enhancer vector and the luc 
reporter gene were chosen for subsequent experiments because of increased 
sensitivity which would help clarify small differences in activity between deletion 
mutants. Constructs were transfected into FDD cell cultures via the calcium 
phosphate precipitation technique. Values represent a mean of three trials, 
normalized with (3-galactosidase activity, with a standard error and statistical 
significance as indicated (Table 9).
Table 9. ALTR3 deletion mutant activity in FDD cell cultures.
CPM/nU B-Gal
Construct Basal Transactivated Fold Increase
pD(-233/-l 85)/Luc 1572±391s 29698± 5517n 19
pD(-181/-135)/Luc 1830±499s 32805 ± 9095n 18
pD(-13 7/-118)/Luc 3180 ±475n 39209 ± 4500n 12
pD(-117/-101)/Luc 4400 ± I0 6 ln 47418 ±2677n 11
pD(-94/-87)/Luc 1406±405s 35819 ±7368n 25
pD(-85/-80)/Luc 2128±592s 38321 ±4792n 18
pD(-77/-61)/Luc 3968 ±1418n 42487 ± 5499n 11
pD(-57/-43)/Luc 1594±363s 23947 ±2148n 15
pD(-46/-31)/Luc 2003±237s 21254±1553s 11
table con’d
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pD(l/26)/Luc 4124±410n 4169 ± 969s 1
pD(32/90)/Luc 5222 ± 1250n 34076 ±4226n 7
pALTR3/Luc 6631 + 1461 43281 ±3164 7
The results showed that every deletion caused some loss of promoter 
strength under basal conditions but that not all decreases were significant. There 
was no indication of a negative regulatory element as seen in previous deletion 
studies. While the activities of some deletion constructs, pD(-l 17/-101)/Luc, 
pD(l/26)/Luc, and pD(32/90)/Luc, were only slightly lower, 21% to 38%, than that 
of the full-length construct, pALTR3/Luc, the majority of the constructs 
demonstrated more dramatic, approximately 50% to 75%, reductions in activity. 
Sequences flanking the hypervariable region seemed to be very important, as shown 
by pD(-94/-87)/Luc, pD(-85/-80)/Luc, pD(-57/-43)/Luc, and pD(-46/-31)/Luc, 
while deletion of 17 base pairs within the large insertion unique to the FDD- 
adapted LTR, as indicated by pD(-77/-61), resulted in only a 40% decrease in 
promoter activity. Surprisingly, the removal of sequences near the beginning of the 
U3 region, demonstrated by pD(-233/-185)/Luc and pD(-181/-l35)/Luc, also had a 
large impact on basal transcription rates resulting in 76% and 72% drops in activity 
respectively. Computer homology searches indicated that this area contains 
imperfect sequence repeats which differ from an NF-kB consensus binding 
sequence (GGGRHTYYHC) (Lenardo and Baltimore, 1989) by only one base pair. 
Deletion of PU.l, pD(-46/-31)/Luc, or PU.l and AP-1, pD(-57/-43)/Luc, sites 
immediately upstream of the TATA box resulted in 70% and 76% drops in activity 
respectively. Therefore, the PU.l element is very important for basal transcription 
levels. It is impossible to conclude whether the AP-1 site is inactive or whether it
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behaves synergistically with the adjacent PU.l site. Removal of the duplicate AP-1 
and PU.l sites, pD(-77/-61)/Luc, had a less dramatic effect resulting in a 40% 
decrease in activity. Deletion of one, pD(-85/-80)/Luc, or both, pD(-94/-87)/Luc, 
PEA2 sites decreased activity 68% and 79% respectively indicating an important 
role for these elements in the control of the LTR in FDD cells. Deletion of large 
portions of the R region, pD(l/26)/Luc, had a modest impact on basal activity 
resulting in a 38% decrease. It is possible this region contains a recognition 
element but no other studies have indicated one in this region. Deletion of the 
remainder of the R and U5 regions, pD(32/90), decreased activity by 21% this 
difference was not significant.
None of the deletions within the U3 region affected the degree of 
transactivation as significantly as the large deletion mutant, pD(^/wI///mcII)/CAT, 
of the Prtt LTR. Under transactivating conditions, all deletion mutants showed 
significant stimulation except pD(l/26)/Luc which deletes the putative EIAV 
transactivation response element (TAR) (Derse et al., 1993). Deletion mutants that 
demonstrated a dramatic loss of basal promoter activity, such as pD(-233/-185)/Luc 
and pD(-94/-87)/Luc, showed considerable stimulation by EIAV Tat, 
approximately 19 and 26 fold increases respectively. Mutants that demonstrated 
basal promoter activity levels near that of the full length ALTR3, such as pD(-l 17/- 
101)/Luc and pD(32/90)/Luc, were stimulated only 11 and 7 fold respectively. As 
seen in the previous expression study with LTR variants, the degree of stimulation 
by transactivation tended to be inversely proportional to the level of basal activity. 
This causes the significant variation in promoter activity between deletion mutants 
under basal conditions to become less distinctive under transactivated conditions. 
Only in the case of pD(-46/-31)/Luc, which deletes the PU. 1 motif closest to the
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TATA box and dramatically reduces basal activity, does this effect not seem to 
apply as induction by Tat for this mutant was only 11 fold. It is possible that this 
deletion may affect the mechanism of transactivation as discussed in the previous 
study of Prtt deletion mutants.
These results indicate a large number of m-elements spread throughout the 
U3 region that act in concert to control transcription from the EIAV LTR and 
which is similar to results obtained from deletion studies of the Bovine 
immunodeficiency virus and Visna-maedi virus LTRs (Fong et al., 1995; Hess et 
al.,. 1989). The most significant elements are clustered near the hypervariable 
region and include the PU.l and PEA2 recognition sites although there appears to 
be an important element(s) in the upstream regions of U3 as well. It is unlikely that 
each deletion resulted in the loss of a recognition element despite the fact that they 
all demonstrated less activity than the full-length LTR. Instead, this may indicate a 
requirement for correct spacing between existing elements. For example, LEF 
imparts a 110° turn in the HIV LTR which is believed to allow factors bound to 
upstream regions to interact with those in proximity to the TATA box. This 
mechanism requires correct spacing between the LEF recognition site and both 
upstream and downstream elements (Jones and Peterlin, 1994). In the Mouse 
mammary tumor virus LTR, exact spacing is required between glucocorticoid 
response elements. The exact spacing allows the two elements to lay in proximity 
to one another when the LTR is assembled with the nucleosome complex (WolfFe, 
1994). It is interesting to note, that Carvalho and Derse (1993) identified an MDBP 
element in the EIAV LTR. MDBP has subsequently been identified as a histone 
HI homologue (Bruhat and Jost, 1995). Spacing may therefore also be important 
between elements in the EIAV LTR upon assembly into chromatin
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Quantitation of Variant LTR Sequences in Infected Horse Tissues
As shown previously, variant LTR behavior is dependent upon cell type. 
The LTR also contains a large number of putative regulatory c/s-elements that may 
allow the virus to respond to a variety of different cellular environments. This 
indicates that LTR variation may play a role in cellular adaptation or tropism in 
vivo. Quantitation of two different types of variant LTR sequences in several horse 
tissues was performed using the technique of competitive PCR. Total DNA from 
liver, lymph node, kidney, and lung tissue of an experimentally infected horse was 
obtained from Dr. Susan Payne. Primer P-l was designed to recognize and amplify 
LTR variants homologous to 3.2-1 while primer P-3 was designed to recognize and 
amplify LTR variants homologous to 3.2-3. In addition to either P-l or P-3 and 
horse tissue DNA, each amplification reaction contained either purified 3.2-1 or
3.2-3 DNA at decreasing concentrations. Both external controls, 3.2-1 and 3.2-3, 
contained an internal deletion allowing their amplification products to be separated 
from the amplification products of the horse DNA by polyacrylamide gel 
electrophoresis.
This study indicated that variant LTR sequences homologous to 3.2-3 were 
by far the most prevalent in all tissues examined (Fig. 7). Amplification of variants 
homologous to 3.2-1 could not be achieved in any tissue even upon extension of the 
reaction to 50 cycles. Distribution of viral DNA was somewhat similar between 
tissues, with liver and lymph node demonstrating a transition from control 
amplification products to horse DNA amplification products between reactions 
containing 3.0 and 0.3 pg external control and 150 ng tissue DNA. The transition 
for kidney tissue occurred at 3.0 pg external control while lung tissue, obtained by 
lung lavage, demonstrated less viral DNA with the transition occurring between
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
77
Figure 7. Quantitation of LTR variants in infected horse tissue DNA. Competitive 
PCR reactions were run with primers specific for variant LTR sequences 
homologous to 3.2-1, as shown by P-l, or with primers specific for variant LTR 
sequences homologous to 3.2-3, as shown by P-3. In addition to 150 ng of tissue 
DNA, reactions contained purified plasmid DNA containing either 3.2-1 or 3.2-3, 
each containing a small deletion, in decreasing amounts, from 300 pg to 0.03 pg.
Cl reactions contained genomic DNA isolated from FDD cell cultures infected 
with virus derived from the molecular clone pSPEIAVAd3 in the case of P-l 
reactions or from FDD cell cultures infected with virus derived from the molecular 
clone pSPEIAV44 in the case of P-3 reactions. C2 reactions did not contain tissue 
DNA. The tissues used were: (Panel A) liver, (Panel B) kidney. (Panel C) lymph 
node, and (Panel D) lung (isolated by lung lavage).
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reactions containing 0.3 and 0.03 pg external control DNA. Assuming 6x10^ kb 
per diploid genome, and 5.3 kb per plasmid control, the number of LTR sequences 
per liver cell is between 2.4 and 24. Numerous studies have shown that EIAV 
infects macrophages almost exclusively. Macrophages in the liver (Kupffer cells) 
account for about 10% of the cells by number (Rice et al., 1989). Assuming a 
100% infection rate and two LTR regions per provirus, the results indicate that each 
liver macrophage contains between 12 and 120 copies of the EIAV pro viral 
genome.
These experiments yielded some very unexpected results. It was very 
surprising that LTR variants homologous in sequence to 3.2-1 could not be 
amplified from any infected horse tissue even with extended cycles. It is not very 
likely that this is the result of poor amplification as the primer P-l recognized and 
amplified the control plasmid. An additional primer, different in sequence from 
primer P-l but specific for 3.2-1, was also tested and failed to amplify any products 
from tissue DNA. In these particular tissues therefore, sequences homologous to
3.2-1 were present in quantities so low, if they were present at all, they can be 
considered irrelevant. Although this experiment was performed with tissue DNA 
from a single animal that was euthanized during its first disease episode shortly 
after infection, it can certainly be speculated that there is no strong selective 
pressure for LTR variants between tissues and that LTR sequences homologous to
3.2-3 are sufficient to enable a pathogenic virus strain to cause acute disease. This 
probably indicates that LTR variants similar to 3.2-3 are the most active promoters 
in vivo and confer a selective advantage upon their own viral genotype. It remains 
to be determined however, if LTR regions homologous to 3.2-3 are required for 
pathogenicity. It is also not known if more divergent LTR sequences would appear
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if the host were allowed to live through multiple disease episodes. These 
experiments also indicated a very high number of proviruses per macrophage based 
upon data for liver tissue (the only tissue for which the percentage of macrophage 
cells was available). Another study used hybridization techniques and calculated a 
proviral copy number of between 6 and 60 per macrophage cell (Rice et al., 1989). 
There are likely explanations for the two-fold discrepancy such as the inherent 
inaccuracy of both experimental techniques and differences in the level of viremia 
or percentage of cells infected between the subject horses. Previous studies using 
immunofluorescence, and hybridization have shown that the liver and lymph node 
are primary sites for EIAV replication. Kidney and lung tissue, while positive for 
EIAV replication and antigen, were not previously shown to be primary sites of 
replication (McGuire et al., 1971; Sellon et al., 1992). In this study however, 
kidney tissue contained the highest proviral copy number of all. Once again, this 
discrepancy may be due to the wide range of error inherent in the experiments 
themselves or differences in the horse subjects. It may also be the result of 
differences in the level of virus expression as the previous studies measured viral 
mRNA and antigen production. It is possible that while a high percentage of 
kidney macrophages are infected they may not be expressing the virus. This 
explanation is supported by two studies which show that EIAV replication is 
restricted to mature tissue macrophages and does not occur in circulating 
monocytes although they do contain proviral DNA (Maury, 1994; Rice et al., 1989, 
Sellon et al., 1992).
Progress of Infection in FDD Cell Cultures
To assess the impact of the LTR on replication capacity and 
cytopathogenicity, ALTR3 was cloned into an infectious molecular clone of EIAV,
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pSPEIAV44. This was accomplished by creating anXhol site within ALTR3 as 
well as within the 3' LTR of pSPEIAV44. The portion of ALTR3 between the Xhol 
and Stul sites was subsequently used to replace the corresponding portion of the 
cognate LTR of pSPEIAV44. Infection of FDD cell cultures by virus derived from 
the resulting clone pSPEIAVAd3 as well as the original pSPEIAV44 and AFDD 
virus strains were monitored by cell proliferation assays, measurement of reverse 
transcriptase activity, Northern and Southern blot analysis, and 
immunofluorescence.
Cell viability was determined daily for all three infections as well as 
uninfected cultures by measuring the reduction of a tetrazolium compound into a 
formazan product that was released into the cell culture media and quantitated.
This procedure measures the overall metabolic activity of the cell culture which is 
directly proportional to the number of viable cells, assuming a similar rate of 
growth. Absorbance measurements obtained during the initial days of infection 
continually increased until the cultures reached confluency after which the 
measurements tapered off to a low point around day 9 (Fig. 8). Measurements 
obtained from uninfected cell cultures and those infected with the pSPEIAV44 and 
pSPEIAVAd3 virus strains slowly rose from the low point on day 9 until the 
maximum propagation time of FDD cell cultures was approached around day 19 
when they dropped severely. Microscopic examination of the cell cultures infected 
with the pSPEIAV44 and pSPEIAVAd3 virus strains gave no indication of any 
cytopathogenic effects during the life-span of the cultures. Absorbance 
measurements obtained from cell cultures infected with the cytopathogenic AFDD 
strain reached a low point at day 13. Microscopic examination of the cell culture
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Figure 8: Cell culture viability for infected and mock-infected FDD cell cultures. 
Assays were performed during the course of the experiment according to 
procedures outlined in Materials and Methods.
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Figure 9. Visual appearance of FDD cell cultures. Both mock-infected (Panel A) 
and AFDD infected (Panel B) FDD cell cultures were stained and photographed ten 
days post-infection. Bar represents a length of 50 uM.
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during this period showed an extreme deterioration of the cell culture monolayer 
and a dramatic reduction, greater than 6 fold by day 13, in viable cells (Fig. 9). As 
the infection progressed, the monolayer was slowly regenerated by cells evidently 
resistant to the cytopathic effects of the virus. Absorbence measurements from the 
culture during this period steadily increased from day 13 to day 18 after which the 
values dropped, as seen in all cell cultures, on day 19.
Based on these observations, it can be concluded that the AFDD LTR alone 
does not confer the cytopathogenicity of the original AFDD strain upon a molecular 
clone. Additional studies such as the measurement of reverse transcriptase 
production, Northern and Southern blot analysis, and immunofluorescence, were 
performed to determine if the replacement of the LTR affected replication kinetics 
or viral phenotype in any way. The subsequent experiments also served to further 
characterize the behavior of the cytopathogenic FDD-adapted virus strain.
Analysis of reverse transcriptase activity was performed by harvesting cell 
culture supernatants every 24 hours and precipitating the virus with polyethylene 
glycol. Solubilized viral pellets were mixed directly with the template 
oligonucleotide and [^H]dTTP. Values represent incorporated CPM minus 
background.
Daily measurement of reverse transcriptase activity in the cell culture media 
showed similar profiles for both the pSPELAV44 and pSPEIAVAd3 strains. Both 
strains show activity steadily increasing during the course of infection to a 
maximum peak of activity on day 17 followed by a rapid decline in activity as the 
maximum propagation time of FDD cell cultures is approached (Fig. 10).
However, even though the curve profiles are similar, cell cultures infected with 
pSPEIAVAd3 consistently exhibited more reverse transcriptase activity than twice
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Figure 10. Reverse transcriptase production by infected FDD cell cultures. 
Production of reverse transcriptase by FDD cell cultures, infected with 
pSVEIAVAd3, pSVEIAV44, or AFDD virus strains, was monitored using the 
procedures outlined in Materials and Methods.
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the activity as pSPEIAV44. FDD cell cultures infected with AFDD produced 
cultures infected with pSPEIAV44. On day 17, pSPELAVAd3 showed almost a 
peak of reverse transcriptase activity by day 14 after which activity steadily 
decreased for the remainder of the infection. Although the activity profile of 
AFDD was similar to the profiles demonstrated by the pSPELAV44 and 
pSPEIAVAd3 virus strains, reverse transcriptase production by AFDD was 
accelerated relative to the other virus strains in that its maximum peak of activity 
occurred three days earlier in infection than the corresponding peaks of activity 
demonstrated by the pSPELAV44 and pSPEIAVAd3 virus strains. In addition, 
AFDD never produced the same levels of activity as the virus strains pSPELAV44 
and pSPEIAVAd3. Its maximum level of activity during the course of infection, 
day 14, was 3 fold less than the maximum level achieved by pSPELAVAd3 on day 
17.
Assuming reverse transcriptase activity is directly proportional to virion 
production and is an accurate measurement of replication capacity, these results 
indicate that the FDD-adapted virus LTR increased the replication capacity of the 
molecular clone. The difference in activity produced by cultures infected with 
pSPEIAVAd3 and those infected with pSPEIAV44 was not due to unequal levels 
of proviral DNA as indicated by subsequent Southern blotting. The study also 
showed that the cytopathogenic effects of AFDD are relatively independent of its 
replication capacity. Therefore, the cytopathogenicity of the AFDD strain is not 
caused by the excessive production and secretion of virions. The actual pattern of 
reverse transcriptase production by AFDD infected cultures is difficult to reconcile 
with the previous study on cell culture viability. Activity produced by AFDD 
began to drop several days in advance of the severe monolayer deterioration
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witnessed by day 13. It is possible that the visible signs of monolayer deterioration 
may lag behind widespread host cell death by a considerable amount of time. 
Although it is impossible to determine from these studies the degree or even the 
actual existence of this lag time, a large time difference between visual 
cytopathogenic effects and the actual onset of cell death may help explain reverse 
transcriptase production, or the lack thereof, by AFDD infected cell cultures late in 
infection. It is possible that the second peak of activity produced between days 13 
and 15 by AFDD infected cultures preceded yet another round of monolayer 
deterioration that was simply never witnessed due to the life-span of the culture 
being reached at day 19.
Analysis of viral mRNA during the course of the infections by Northern 
blot indicated little difference between the pSPEIAV44 or pSPEIAVAd3 strains at 
the mRNA level. Northern blot analysis of total RNA from infected cell cultures 
showed three characteristic EIAV specific mRNA bands: an 8.2 kb band, the 
unspliced mRNA which produces the gag and pol gene products as well as serving 
as virion RNA; a 3.2 kb band, a singly-spliced mRNA species that produces the env 
as well as the S2 open reading frame gene products and EIAV Tat; and a 1.5 kb 
band, consisting of multiply-spliced mRNA species that produce the EIAV Tat, 
Rev, and the non-characterized Ttm proteins (Derse et al., 1993; Rasty et al., 1990). 
Upon poIy-A RNA selection, the 1.5 kb viral mRNA species decreased to virtually 
undetectable levels (Fig. 11). Both the pSPEIAV44 and pSPEIAVAd3 infections 
show a low abundance of viral mRNA early in the infection, detectable only by day 
6, which increases during infection, illustrated by day 12, and then rapidly 
decreases as the host cell culture reaches the end of its life-span, shown by day 18. 
Both infections show a more intense 3.2 kb band relative to the 8.2 kb band. The
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Figure 11. Analysis of viral mRNA by Northern blot hybridization. Poly-ARNA 
isolation from infected FDD cell cultures and Northern blot hybridization was 
performed as outline in Materials and Methods. Location and identification of 
molecular weight size markers is indicated at the left as is a mock-infected control 
(lane B). (Panel A) Analysis of viral mRNA produced by cultures infected with 
pSPEIAVAd3 on day 6 (lane 1), day 12 (lane 2) and day 18 (lane 3) post-infection. 
(Panel B) Analysis of viral mRNA produced by cultures infected with pSPEIAV44 
on day 6 (lane 4), day 12 (lane 5) and day 18 (lane 6) post-infection. (Panel C) 
Analysis of viral mRNA produced by cultures infected with AFDD on day 6 (lane 
7), day 12 (lane 8) and day 18 (lane 9) post-infection. Markers at right indicate the 
approximate sizes of the three viral mRNA species detected.
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AFDD infected cell cultures show a dramatic increase, at least 10 fold, in the 
overall amount of viral mRNA relative to the pSPEIAV44 and pSPEIAVAd3 
infections. This strain produced a large amount of viral mRNA detectable by day 
6, which then slightly decreased during the course of infection, as indicated by day 
12 and day 18. Both the 3.2 kb and 8.2 kb bands showed a similar intensity.
Based upon these results, it can be concluded that despite an increased basal 
transcription activity, the AFDD LTR had no detectable influence on viral mRNA 
production by the molecular clone and that neither pSPEIAVAd3 nor pSPEIAV44 
produced the large amount of viral mRNA demonstrated by cultures infected with 
AFDD. In actuality, the technique of Northern blotting is prone to a great deal of 
variation between trials and between individual samples. This inherent inaccuracy 
of the technique coupled with the fact that these blots are based upon only one trial 
makes the strict quantitative interpretation of these results questionable. Although 
there is no doubt that AFDD produces far more viral mRNA than pSPEIAVAd3 
and pSPEIAV44, it cannot be concluded with any reasonable certainty whether 
there are small quantitative differences in viral mRNA levels produced by 
pSPEIAVAd3 and pSPEIAV44.
Southern blotting was performed in order to monitor the relative levels of 
proviral DNA present in infected cell cultures. Total cellar DNA was isolated and 
purified from infected cell cultures and digested to completion with Stul. This 
cleaves EIAV proviral DNA once in each LTR. Upon complete digestion, a 
roughly 8.2 kb EIAV proviral DNA band should be produced. Examination of the 
results obtained from this experiment showed that cultures infected with 
pSPEIAVAd3 and pSPELAV44 contained approximately the same amount of 
proviral DNA, relative to one another, throughout the course of infection (Fig. 12).
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Figure 12. Analysis of cellular DNA by Southern blot hybridization. Total 
cellular DNA was isolated from infected FDD cell cultures, digested to completion 
with Stui, and subjected to Southern blot analysis according to the procedures 
outlined in Materials and Methods. The location and size of molecular weight 
markers are indicated at the left as is a mock-infected control (lane B). (Panel A) 
Cellular DNA isolated from cultures infected with pSPEIAVAd3 on day 6 (lane 1), 
day 12 (lane 2), and day 18 (lane 3) post-infection. (Panel B) Cellular DNA 
isolated from cultures infected with pSPEIAV44 on day 6 (lane 4), day 12 (lane 5), 
and day 18 (lane 6) post-infection. (Panel C) Cellular DNA isolated from cultures 
infected with AFDD on day 6 (lane 7), day 12 (lane 8), and day 18 (lane 9).
Marker at right indicates the approximate size of digested proviral DNA.
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Both cultures showed a somewhat weak, approximately 8.2 kb band by day 6 post­
infection which gradually increased in intensity during the course of infection as 
illustrated by results obtained on days 12 and 18. Cultures infected with AFDD 
once again produced markedly different results, exhibiting a 8.2 kb band by day 6 
which increased in intensity even more during the course of infection, as illustrated 
by results from day 12, and then decreased slightly as the end of the culture life­
span was approached at day 18.
Once again, it must be stated that precise quantitative interpretation of these 
blots is questionable due to their own inherent imprecision and the lack of multiple 
trials. Clearly, AFDD infected cultures contained considerably more proviral DNA 
than cultures infected with pSPEIAVAd3 and pSPEIAV44. This finding throws 
considerable doubt upon the theory that the accelerated cytopathogenicity exhibited 
by AFDD is caused by the production of increased amounts of viral mRNA. Taken 
together, the results obtained from the Northern and Southern blots seem to indicate 
that AFDD proviral DNA produces amounts of mRNA comparable to that 
produced by pSPEIAVAd3 or pSPEIAV44 but that AFDD infections result in 
considerably more proviral DNA. Cytopathogenic retrovirus strains that exhibit 
increased amounts of proviral DNA have been extensively studied and this 
phenotype is believed to result from the loss of host cell immunity to super­
infection by the virus strain. Changes in the virus-host cell recognition process can 
result in the inability of the virus to down-regulate its own host cell receptor later 
on in infection.
In order to determine if the increased amounts of proviral DNA and viral 
mRNA produced by FDD cultures infected with AFDD were due to super-infection 
or simply due to a larger percentage of host cells being infected,
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immunofluorescence studies were performed to determine the percentage of cells 
expressing EIAV antigen within a culture. In brief, samples of cell cultures at 
various stages post-infection were fixed on slides and incubated with a rabbit 
polyclonal antiserum raised against a peptide corresponding to gp90, the surface 
protein of EIAV. Subsequent incubation with a Fluorescein conjugated antiserum 
against rabbit IgG and microscopic examination under both visible and blue light 
allowed the determination of the percentage of cells containing gp90 which is a 
strong indication that the cells are infected with EIAV (Appendix A).
Cultures infected with AFDD showed a high percentage, 25%, of 
fluorescent cells as early as day 6 which increased during the infection to 
approximately 40% on day 12 and 36% on day 18. Cultures infected with 
pSPEIAVAd3 yielded no detectable fluorescence until day 12 when approximately 
10% of the host cells expressed antigen. By day 18, this percentage had risen 
sharply to 50%. Cultures infected with pSPEIAV44 gave similar results, not 
demonstrating a strong amount of fluorescence until day 18 at which time 40% of 
the host cells expressed antigen.
The large percentage of fluorescent cells detected in cultures infected with 
AFDD is in agreement with the previous results obtained from Northern and 
Southern blotting. These results indicate that, to some extent, increased amounts of 
proviral DNA and viral mRNA detected in AFDD infected cultures, relative to 
cultures infected with pSPEIAVAd3 and pSPEIAV44, was due to a higher 
percentage of host cells being infected. This does not reconcile all results, 
however. Whereas cultures infected with pSPELAVAd3 and pSPEIAV44 contained 
a large percentage of fluorescent cells later in infection but Northern and Southern 
blot analysis still indicated lower levels of proviral DNA and viral mRNA relative
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to cultures infected with AFDD. It must be noted, however, that samples harvested 
on day 18 post-infection were used to represent the late stages of infection. By this 
time, cell cultures were approaching the end of their life-span and both cell viability 
and reverse transcriptase production were dropping.
Overall, these studies indicate that replacement of the LTR region of a 
molecular clone, pSPEIAV44, by the corresponding region of AFDD failed to 
confer cytopathogenicity upon the chimeric molecular clone, pSPEIAVAd3, but did 
affect replication capacity, as shown by measurements of cell proliferation and 
reverse transcriptase production. Detailed examination of the infections by these 
and a variety of other techniques revealed several significant insights into the 
behavior of the AFDD virus strain. Immunofluorescence studies as well as 
Northern and Southern blot analysis agreed that the AFDD infects a large 
percentage of the host cell culture which exhibit high levels of viral mRNA, 
proviral DNA, and surface protein. Oddly, reverse transcriptase production by 
these cultures was very low. It is possible that this represents a defect in proper 
virion assembly and release. This defect may also result in the super-infection of 
the host cell as Southern blot analysis indicates that even late in infection, when 
cultures infected with pSPEIAVAd3 and pSPEIAV44 are releasing far more 
reverse transcriptase activity and have infected comparable percentages of host 
cells relative to cultures infected with AFDD, they do not exhibit comparable levels 
of proviral DNA. Of course, the lack of induction seen at the viral mRNA and 
proviral DNA level in cultures infected with pSPEIAVAd3 and pSPEIAV44 as 
infections progressed is also noteworthy. The low levels of viral mRNA and DNA 
indicated in the blots may be deceiving as samples were taken on day 18 post­
infection when cell culture viability and reverse transcriptase production were
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dropping. It still seems unlikely however, that the levels would drop so 
dramatically in such a short period of time.
Although far from conclusive, a possible description of the AFDD 
replication cycle in FDD cell cultures can be constructed. Initial infection of the 
cultures results in widespread infection and the rapid appearance of infectious 
virions in the culture supernatant. As the levels of virions rises the majority of host 
cells become super-infected resulting a decrease in intact virion production and host 
cell death. Subsequently, cells that had escaped super-infection rapidly proliferate 
and, once again, high levels of infectious virions begin to accumulate in the 
supernatant resulting in a continuing cycle of virus production followed by host cell 
super-infection and death.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 4 
SUMMARY AND CONCLUSIONS
Prior to this investigation, very little information was known about the 
EIAV LTR and how transcription of the EIAV genome was regulated. Preliminary 
studies had shown a high degree of LTR sequence variation between virus isolates 
obtained from sequential disease episodes of an infected pony (Payne et al., 1987). 
Comparison of the variant LTR isolates indicated that the sequence variation was 
primarily located in a specific region approximately 60 base pairs upstream of the 
TATA box. This region of the LTR, later dubbed the hypervariable region, was 
prone to sequence insertions or duplications. Deletion studies performed in FEA 
cell cultures showed that c/s-elements in proximity to the hypervariable region had 
a dramatic impact on basal transcription (Dorn and Derse, 1988). Examined 
together, these experiments indicated that elements critical for the assembly of the 
basal transcription complex might be duplicated or changed in certain LTR 
variants. It was further postulated, that LTR sequence variation may increase the 
replication capacity of the virus influencing its pathology or allow the virus to adapt 
to new cellular environments thereby influencing cellular adaptation or tropism. 
Macrophages are a very heterogeneous cell type varying considerably in phenotype 
between different locations in vivo (Weinberg and Athens, 1993). These 
microscopic and antigenic differences must reflect differences at the molecular 
level. LTR heterogeneity may allow the virus to infect the many different sub­
populations of macrophages resulting in a more extensive infection of the host and 
the high level of viremia required to cause acute disease. In the absence of a 
pathogenic molecular clone, experiments designed to test these theories were 
performed primarily in vitro.
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Sequence comparison between the highly characterized Prtt LTR sequence 
and LTR variants isolated from diverse sources such as an infected pony, a tissue 
culture-adapted strain of EIAV, and an infectious EIAV molecular clone, indicated 
a number of sequence differences that could affect promoter strength. The most 
significant differences occurred in the hypervariable region of the EIAV LTR and 
resulted in imperfect duplication of the putative AP-1 and PU.l or interruption of 
the PEA2 transcription factor motifs identified within Prtt (Carvalho and Derse, 
1993a; Carvalho and Derse, 1993b). Variant LTR sequences from a tissue culture- 
adapted strain, ALTR3 and ALTR4, as well as one variant from an infected pony,
3.2-1, contained duplications of the putative PU.l and AP-l sites while retaining 
both PEA2 sites. The cognate LTR of an infectious molecular clone, PV44, and an 
additional horse isolate, 3.2-3, contained a duplication of the PU.l element but this 
mutation interrupted one PEA2 motif. The final horse isolate, 3.2-5, contained two 
additional putative PU.l motifs and possibly an additional AP-1 site as well. 
Similar to the two previous LTR variants discussed, it contained an insertion which 
interrupted the PEA2 motif. Based on this analysis, most LTR variants can be 
placed into two general classes based upon sequence homology which differ 
significantly in the transcription factor elements they contain.
Transient gene expression studies performed in FDD cell cultures using 
these same LTR variants indicated significant disparities between basal promoter 
activities overall but similar activity levels between variants belonging to the same 
family. Variants ALTR3, ALTR4 and 3.2-1 all showed dramatically higher levels 
of activity than Prtt, PV44,3.2-3, and 3.2-4. This indicates that AP-l and PEA2 
binding motifs may be very important for LTR promoter strength in FDD cell 
cultures. These differences became less pronounced when cells were co-transfected
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with an EIAV Tat expression plasmid but were still significant. Deletion mutants 
created from Prtt, pD(^/uI////wcII)/CAT, and pD(//mdIH/<4/Ml)/CAT, which remove 
the hypervariable region and U3 sequences upstream of the hypervariable region 
respectively, indicated that elements in proximity to the hypervariable region as 
well as in the upstream regions of the U3 were important for basal transcription. 
Complete removal of the hypervariable region also decreased the magnitude of 
transactivation. Similar assays were performed in FEA cell cultures but with only 
the three horse isolates, Prtt, and the Prtt deletion mutants. The three horse isolates 
were all more active promoters than Prtt but the differences in the basal levels of 
activity, while significant, were not as dramatic as in FDD cell cultures. These 
results implicate the PU.l site in LTR behavior in FEA cells. Under transactivating 
conditions the differences in activity between variants became insignificant. 
Deletion of the hypervariable region had far less an impact on basal transcription 
than that seen in FDD cell cultures and removal of upstream U3 sequences actually 
increased activity indicating the presence of a possible negative regulatory element. 
Similar to the effect in FDD cells, removal of the hypervariable region decreased 
the magnitude of transactivation. In Cf2Th cells, Prtt and 3.2-1 were the most 
active promoters under basal conditions although the differences in activity levels 
between these two variants and the remaining two were not as dramatic as seen in 
FDD cell cultures. Under transactivating conditions, no variants maintained a 
significantly higher activity. These results implicate the PEA2 sites in regulating 
the LTR in Cf2Th cells. Deletion of both the hypervariable region and upstream 
U3 sequences had only a moderate impact on basal transcription while deletion of 
the hypervariable region abrogated transactivation completely.
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In conclusion, LTR variants behave differently depending upon cell type. 
Therefore, LTR variation may play a role in tissue adaptation or tropism. Although 
highly speculative, c/s-elements important in controlling basal transcription from 
the LTR were putatively identified, and the requirement of a c/s-element, in 
proximity to the TATA box, for efficient transactivation was demonstrated. It is 
impossible to discern whether the cell dependent behavior of the LTR variants 
reflects differences in the tissue sources or differences in species origin of these cell 
lines. FEA and Cf2Th cell lines were chosen on the basis of their ability to support 
replication of EIAV, their use in previous studies, and the unavailability of non- 
dermal equine cell lines. Because of their non-equid origins, additional studies in 
these cell lines could not be justified despite the interesting observations made. 
Peripheral blood macrophages could be obtained but not in large quantities, 
required extensive purification, and were difficult to maintain. Although attempted, 
transient transfection with reporter plasmids could never be achieved 
Subsequently, the remaining experiments were all performed FDD cell cultures.
To further localize the c/s-elements within the EIAV LTR active in FDD 
cell cultures, a more extensive deletion analysis was performed using the AFDD 
LTR as a template. These deletion mutants revealed that sequences proximal to the 
hypervariable region, which includes the AP-1, PU.l, and PEA2 motifs originally 
identified within the prototype LTR, were highly important for basal transcription. 
Deletion of the additional AP-1 and PU.l sites created by the sequence insertion 
had only a moderate effect on basal transcription indicating that other sequence 
variations contribute to the increased promoter strength of the AFDD LTR. 
Deletions within the first 100 base pairs of the U3 region also had a dramatic 
impact on basal promoter strength. No specific c/s-elements within this area of the
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EIAV LTR have previously been identified nor did previous deletion studies 
indicate that this area had as great an effect on basal transcription as seen here 
(Carvalho and Derse, 1993a; Carvalho et al., 1993). None of the deletions had as 
dramatic an impact on the magnitude of transactivation as did the Prtt deletion 
mutant pD(^/wI////«cII)/CAT. This may indicate that a specific crs-element is not 
required but that any active element in proximity to the TATA box is sufficient for 
efficient transactivation to occur.
These studies indicate that in FDD cell cultures, the EIAV LTR may contain 
two core enhancer units; one centered within the hypervariable region and proximal 
to the TATA box, the other within the first 80 base pairs of the U3 region. The 
presence of multiple enhancer elements may allow the LTR to respond to a wide 
variety of cellular environments. Of course, none of the elements or the factors that 
recognize them have been definitively identified here. More extensive studies, such 
as DNase 1 protection and mobility shift assays, were not performed. While the 
deletion mutant experiments were being conducted, extensive studies on the 
transcription factor complexes formed with EIAV LTR variants were published 
making the results presented here merely confirmatory. Any future studies would 
require a repetition of these assays in a monocytic cell line or, preferably, in 
primary horse macrophage cultures with an emphasis on identifying the unknown 
upstream elements should they be active in a monocyte/macrophage cell type.
In order to implicate LTR variability in cellular adaptation in vivo, 
competitive PCR was performed with tissue DNA isolated from an acutely infected 
horse using primer pairs specific for two different types of LTR variants. These 
assays indicated that liver, lymph node, and kidney tissue were all infected at 
roughly equivalent levels with virus possessing an LTR homologous to horse
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isolate 3.2-3. Lung tissue, isolated by lung lavage, was infected at lower levels but 
also contained LTR sequences homologous to 3.2-3. Sequences homologous to
3.2-1 could not be amplified even under extended conditions. In this case, LTR 
heterogeneity was neither required for the onset of acute disease nor was it even 
detected at significant levels. It would be interesting to use this system to analyze 
LTR heterogeneity in an infected horse over a longer time period. The host in this 
case was euthanized during the first acute disease episode and there may not have 
been sufficient time allowed for LTR divergence to arise
Replication of the FDD-adapted strain, AFDD, of EIAV in FDD cell 
cultures presents a unique system for studying the viral determinants of replication 
capacity or cytopathogenicity. Both the env and LTR regions are likely candidates 
to contain these determinants as sequence comparison of EIAV isolates indicate 
that these regions are prone to a high degree of sequence variability and that both 
these regions influence replication capacity or cytopathogenicity in other lentivirus 
systems (Brown et al., 1988; Carpenter et al., 1991; Dewhurst et al., 1990; Englund 
et al., 1991; Golub et al., 1990; Payne et al. 1987). In a recent study, Cook et al. 
(1995) replaced a region of env, which codes for the surface protein gp90, of the 
infectious molecular clone, pSPEIAV44, with the corresponding region from 
AFDD proviral DNA. The chimeric clone produced did not show any 
cytopathogenic effects when replicated in FDD cell cultures.
A similar result was obtained in this study in which the LTR region of 
AFDD was placed into pSPEIAV44. The resulting molecular clone, pSPEIAVAd3, 
did not display any discernible cytopathogenic effects when replicated in FDD cell 
cultures although it did demonstrate a higher replication capacity than pSPEIAV44. 
Assuming reverse transcriptase activity correlates directly with virus production,
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reverse transcriptase assays performed on infected cell culture supernatants 
indicated that pSPEIAVAd3 produced approximately twice as much virus as 
cultures infected with pSPEIAV44. Cultures infected with AFDD showed the least 
amount of virus production of all, indicating that the cytopathic nature of AFDD is 
relatively independent of its virion production. Strangely, Northern and Southern 
blot analysis indicated enormous amounts of viral mRNA and DNA in AFDD 
infected cell cultures and immunofluorescence studies indicated large amounts of 
surface protein antigen as well. Therefore the AFDD strain seems capable of super- 
infecting the host culture and possesses a deficiency in virion maturation and 
egress. Which of these characteristics results in its accelerated cytopathogenicity is 
impossible to determine. Any future studies on this virus will have to confirm 
these results and analyze, as of yet, untested regions of the genome.
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